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ABSTRACT
MECHANISMS AND MITIGATION OF SKELETAL MUSCLE FATIGUE IN
SINGLE FIBERS FROM OLDER ADULTS
MAY 2019
AURORA DANAE FOSTER, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Mark S. Miller

Skeletal muscle fatigue is the contraction-induced decline in whole muscle force
or power, and can be greater in older versus young adults. Fatigue primarily results from
increased metabolism elevating phosphate (Pi) and hydrogen (H+), which alters myosinactin interactions; however, which steps of the myosin-actin cross-bridge cycle are
changed and their reversibility are unclear. PURPOSE: This study sought to: 1) Examine
the effects of elevated Pi and H+ on molecular and cellular function, and 2) Test the
ability of deoxyadenosine triphosphate (dATP), an alternative energy to adenosine
triphosphate (ATP), to reverse the contractile changes induced with high Pi and H+.
METHODS: Maximal tension (force/cross-sectional area), myofilament mechanics and
myosin-actin cross-bridge kinetics were measured in 214 single fibers (104 type 1) from
the vastus lateralis of eight (4 men) healthy, sedentary older adults (71±1.3 years) under
normal (5 mM Pi, pH 7.0), simulated fatigue (30 mM Pi, pH 6.2) and simulated fatigue
with dATP conditions. RESULTS: Tension declined with high Pi and H+ in slow- (type I,
23%) and fast-contracting (type II, 28%) fibers due to fewer strongly bound myosin heads
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(28-48%) and slower cross-bridge kinetics (longer myosin attachment times (ton) (18-40%)
and reduced rates of force production (18-30%)). Type I myofilaments became stiffer with
high Pi and H+ (48%), which may have partially mitigated fatigue-induced tension
reduction. Elevated Pi and H+ with dATP moderately improved force production similarly
in both fiber types (8-11%) compared to high Pi and H+ with ATP. In type I fibers, high Pi
and H+ with dATP returned the number of myosin heads strongly bound and ton to normal,
while the rate of force production became faster than normal (16%). In type II fibers, high
Pi and H+ with dATP did not change the number of myosin heads bound, but cross-bridge
kinetics were 16-23% faster than normal. CONCLUSION: These results identified novel
fiber-type specific changes in myosin-actin cross-bridge kinetics and myofilament
stiffness that help explain fatigue-related force reduction in human single skeletal muscle
fibers as well as an alternative energy source that partially to fully reverses contractile
changes of elevated Pi and H+ that occur with fatigue.
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CHAPTER 1
INTRODUCTION
1.1 Background
Skeletal muscle fatigue occurs when hard or continuous contractions reduce the
ability of muscles to generate power due to reduced force and/or velocity (Power = Force
× Velocity) (Callahan & Kent-Braun, 2011; Katsiaras et al., 2005; Kent-Braun et al.,
2012). Older adults are especially susceptible to fatigue-related decrements since they
tend to fatigue quicker and to a greater extent than young adults during rapid dynamic
contractions (Hicks et al., 2001; Katsiaras et al., 2005; Callahan & Kent-Braun, 2011;
Christie et al., 2011; Broxterman et al., 2017; Sundberg, Kuplic et al., 2018), which may
be due to altered cellular and molecular contractile properties with age (Trappe et al.,
2003; Ochala et al., 2007; Callahan & Kent-Braun, 2011; Miller et al., 2013). Decreased
muscle power that characterizes fatigue increases an older adult’s risk for falls
(Schwendner et al., 1997; Wolfson et al., 1995) and frailty (Theou et al., 2008),
indicating reduced physical function. Older adults with reduced physical function are
more likely to be hospitalized (Cawthon et al., 2009), which leads to greater personal and
societal burden. These fatigue-related issues in older adults will be exacerbated by the
fact that the older population (aged 65+ years) in the U.S. is increasing and is expected to
constitute 22% of our population (82 million people) by the year 2040 (Ortman et al.,
2014).
The build-up of metabolic by-products, primarily phosphate (Pi) and hydrogen
(H+) (low pH), are temporally associated with fatigue (Kent-Braun et al., 1993; Kent	
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Braun et al., 2002; Broxterman et al., 2017) and are thought to inhibit muscle
performance at the molecular and cellular levels (Debold et al., 2016), ultimately leading
to decreased whole muscle and whole body function. Understanding the mechanisms and
potential treatments for fatigue at the cellular and molecular levels are important to
mitigate or reverse fatigue-related declines in whole muscle and whole body function,
especially in older adults who are most affected by fatigue. Fatigue can be studied in vitro
by elevating metabolites in the bathing solutions of single muscle fibers and isolated
myosin-actin proteins in order to simulate the biochemical changes that occur during
fatigue in vivo. Elevated Pi and H+ are presumed to be the primary metabolites that
decrease muscle function during fatigue. Most other metabolites and substrates that
change with fatigue are thought to play a minimal role in altering contractile properties
(elevated adenosine diphosphate and reduced adenosine triphosphate, (Cooke, 2007)) or
are lacking accurate measurement techniques (elevated reactive oxygen and nitrogen
species, (Debold et al., 2016; Westerblad & Allen, 2011)), while others may not be as
important for relatively short duration fatigue in vivo (reduced calcium concentration,
(Allen et al., 1989; Lee et al., 1991; Westerblad et al., 1989)). Therefore, this study
focused on simulated fatigue in vitro with elevated Pi and low pH.
Reduced power that characterizes fatigue can be caused by a reduction in force
and/or velocity production, therefore single fiber and isolated myosin-actin studies have
examined the effects of the putative agents of fatigue on power, force, velocity, and the
molecular determinants of these parameters. Simulated fatigue at the molecular and
cellular levels has mostly been studied using young animal tissue, with only one recent
study in tissue from young and older men. Both slow- (myosin heavy chain I or MHC I)
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and fast- (MHC II) contracting single skeletal muscle fibers from young animals and men
exposed to elevated Pi and low pH at near-physiological temperatures (30°C) to simulate
fatigue exhibited decreased maximal velocity and force production (Karatzaferi et al.,
2008; Nelson et al., 2014; Sundberg, Hunter et al., 2018). The most recent fiber studies in
rats (Nelson et al., 2014) as well as young and older men (Sundberg et al., 2018) showed
a leftward shift in the force-velocity curve with fatigue, indicating depressed force and
velocity across the entire range of both parameters, which decreased power production
throughout the entire fiber force-generating range. Reduced fiber force and velocity with
fatigue are largely due to alterations in the interactions between the two primary
contractile proteins, myosin and actin, though the exact mechanisms remain uncertain
(Debold et al., 2016).
Slowed single fiber velocity with high Pi and H+ may be due to longer myosin
attachment times to actin (ton) (slower cross-bridge kinetics) at the molecular level.
Results from unloaded isolated protein in vitro motility assays have suggested that
elevating the putative agents of fatigue lengthened ton in single myosin molecules, if
velocity is assumed to be limited by myosin detachment (H. Huxley, 1990; Debold et al.,
2008; Debold et al., 2012). Single fiber experiments under loaded, control conditions not
simulating fatigue also suggest that slowed fiber velocity occurred because of longer ton
(Piazzesi et al., 2007; Miller et al., 2017), making longer ton a probable cause for slowed
velocity with fatigue assuming a detachment-limited model of the cross-bridge cycle.
However, ton has not yet been measured in single fibers under conditions that simulate
fatigue.
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Fiber force and therefore tension (force/cross-sectional area (CSA)) are largely
determined by the number of strongly bound myosin-actin cross-bridges multiplied by
the force exerted by each cross-bridge (A. F. Huxley, 1957; Brenner, 1988; Linari et al.,
2004), so both or either of these parameters may decrease in order to reduce force with
fatigue (Nocella et al., 2011; Nelson et al., 2014). The number of strongly bound crossbridges is dictated by myosin-actin cross-bridge kinetics, myosin attachment time (ton)
and rate of myosin force production, which influences myosin detachment time (toff). If
we assume that, in fibers exposed to high Pi and H+, slowed velocity occurs due to longer
ton in a detachment-limited model, the concomitant decrease in force could occur due to
1) an even greater increase in toff than ton that reduces the number of strongly bound heads
at any given time and/or 2) a reduction in the amount of force generated by each myosinactin cross-bridge. The few studies that have examined these mechanisms reached
different conclusions. One study found that force initially declined due to reduced force
generation per cross-bridge (cross-bridge stiffness), while greater force reductions
occurred as the number of strongly bound myosin heads were reduced over time (Nocella
et al., 2011). Another study showed that the rate of myosin weak to strong binding
transition (measured by ktr, or rate of force redevelopment) was unchanged in single
fibers in elevated Pi and low pH conditions, but maximal fiber force was hypothesized to
decrease due to reduced force per cross-bridge (Nelson et al., 2014). A new study in
fibers from young and older men found that ktr slowed with high Pi and H+ (Sundberg et
al., 2018), suggesting that reduced force with simulated fatigue may be due to longer toff
and therefore fewer strongly bound cross-bridges. Finally, one recent isolated protein
study using the laser trap assay found that high Pi and low pH reduced the force produced
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by each myosin molecule and its energy utilization rate (ATPase), which indicates longer
ton and/or toff (Woodward & Debold, 2018). Overall, more work needs to be done to
determine the molecular and cellular determinants of reduced fiber force under fatiguing
conditions.
Some promising data suggests that fatigue-related decrements in muscle function
can be reversed by substituting the muscle’s primary energy source, adenosine
triphosphate (ATP), with a naturally occurring ATP analogue, deoxyadenosine
triphosphate (dATP). One in vitro motility study using isolated proteins from young
animal muscle showed that dATP reversed the decrease in regulated thin filament
velocity as a result of elevated Pi and low pH back to control levels (Longyear et al.,
2014). Non-fatigued young rabbit fibers activated with dATP produced similar tensions
and faster contractile velocities compared to fibers activated with ATP (Regnier et al.,
1998; Regnier & Homsher, 1998), demonstrating that dATP also improves cellular-level
contractile function under non-fatigue conditions. These studies suggest that dATP
improves single fiber function both with and without elevated Pi and H+ conditions,
making it a potential target for a fatigue countermeasure.

1.2 Statement of the Problem
	
  

The exact cellular and molecular mechanisms of fatigue are currently unclear
since few single fiber or molecular studies have simulated fatigue in vitro by combining
high Pi and H+, the two major metabolites that alter muscle function and change
concurrently with fatigue in vivo. The mechanisms of the reductions in the determinants
of fiber power, maximal velocity and force, with elevated Pi and low pH are unclear. The
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effects of high Pi and H+ on an important determinant of fiber velocity and force, ton, have
only been hypothesized using in vitro motility experiments with low pH only (Debold et
al., 2008; Debold et al., 2012; Debold et al., 2016). These molecular data should be
verified in single fibers exposed to high Pi and H+ conditions since single fiber
experiments maintain the sarcomere’s three-dimensional structure and the load that actin
imposes on myosin (Miller et al., 2013). Other important determinants of fiber force at
the cellular (myofilament stiffness) and molecular (number of strongly bound myosin
heads, force per cross-bridge and rate of myosin force production) levels should be
further examined since current studies have shown inconsistent results in how these
parameters change with fatigue.
To my knowledge, most single fiber studies have examined the effects of high Pi
and low pH in fibers from young animals with only one recent study using fibers from
young and older men. Fibers from humans have inherently different contractile properties
than those from animals, such as slower velocity due to slower cross-bridge kinetics
(Pellegrino et al., 2003), which implies that different species may have distinct responses
to high Pi and H+ conditions. In addition, simulated fatigue studies using fibers from
older adults are needed since this population is more affected by fatigue during dynamic
whole muscle contractions than their young counterparts (Hicks et al., 2001; Katsiaras et
al., 2005; Callahan & Kent-Braun, 2011; Christie et al., 2011; Broxterman et al., 2017;
Sundberg et al., 2018), which may be due to altered mechanical and kinetic properties
with age (Trappe et al., 2003; Ochala et al., 2007; Miller et al., 2013). Importantly, men
and women may respond differently to fatigue at the whole muscle level (Hicks et al.,
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2001; Labarbera et al., 2013) and to aging at the cellular and molecular levels (Miller et
al., 2013), indicating the importance of examining the response of both sexes to fatigue.

1.3 Study Approach
The objectives of this study were to: 1) Determine the mechanisms of fatigue that
decrease skeletal muscle performance at the cellular and molecular levels in single human
skeletal muscle fibers from older men and women and 2) examine the efficacy of a
potential countermeasure, dATP, to mitigate or reverse fatigue-related declines in skeletal
muscle function at the cellular and molecular levels. Skeletal muscle cellular and
molecular function was measured in 214 single fibers (104 type I, 110 type II) from the
vastus lateralis of eight healthy, sedentary older adults (4 men). In vivo fatigue was
simulated by activating fibers in solutions containing the highest recorded levels of Pi (30
mM vs. 5 mM) and H+ (pH 6.2 vs. 7) in fatigued human whole muscles (Hermansen &
Osnes, 1972; Metzger & Fitts, 1987; Cady et al., 1989; Broxterman et al., 2017). Single
fiber function was characterized by measuring tension, which is force normalized to
cross-sectional area, to allow for comparison among fibers of different sizes. Smallamplitude sinusoidal length perturbation analysis was used to determine myofilament
mechanical properties, including myosin-actin cross-bridge mechanics (cross-bridge
number and stiffness) and kinetics (myosin attachment time and rate of myosin force
production) as well as myofilament stiffness. Aims and hypotheses are outlined below
and in Figure 1.
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1.4 Aims and Hypotheses
1.4.1 Aim 1
Determine the effects of simulated fatigue on tension and myofilament mechanical
properties, including myosin-actin cross-bridge kinetics, in single fibers from older men
and women.

1.4.1.1 Hypotheses for Aim 1
Simulated fatigue will 1A) decrease single fiber tension, due to 1B) a reduction in the
number or stiffness of strongly bound myosin heads, and 1C) slower cross-bridge
kinetics, including increasing myosin attachment time (ton), in type I and II fibers.

1.4.2 Aim 2
Determine the ability of dATP to reverse simulated fatigue-induced changes in tension
and myofilament mechanical properties in single fibers from older men and women.

1.4.2.1 Hypotheses for Aim 2
Simulated fatigue with dATP will 2A) recover tension back to control values, due to its
ability to 2B) recover the number or stiffness of strongly bound myosin heads and 2C)
cross-bridge kinetics, in type I and II fibers.
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Figure 1. Proposal aims and hypotheses. Aim 1 (left column) compares fatigue
(elevated Pi and H+) to non-fatigue (control) conditions. Aim 2 (right column)
compares fatigue with the addition of deoxyadenosine triphosphate (dATP) instead of
adenosine triphosphate (ATP) to non-fatigue conditions. Various parameters at the
single fiber and molecular levels (middle column) were examined. A red downward
arrow indicates a relative decrease with fatigue or fatigue + dATP compared to
control, a green upward arrow indicates a relative increase, and a black horizontal
arrow indicates no difference.
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CHAPTER 2
LITERATURE REVIEW

2.1 Introduction
This literature review will first provide a general overview about the effects of
skeletal muscle fatigue on older men and women at the whole body and whole muscle
levels and why cellular and molecular alterations are important determinants of fatigue.
Second, the in vivo biochemical changes that characterize fatigue in humans will be
examined. Third, the currently known effects of simulated fatigue on cellular and
molecular function will be examined from primarily animal studies as only one human
study has been published to date. Finally, this review will examine the efficacy of
deoxyadenosine triphosphate (dATP) as a potential treatment to counteract fatigueinduced decrements in skeletal muscle performance at the cellular and molecular levels.

2.2 Skeletal Muscle Fatigue
	
  

2.2.1 Whole Body and Whole Muscle Alterations in Older Adults

Intense and/or continuous muscle contractions eventually cause whole skeletal
muscles to fatigue, or decrease their ability to produce power, because of reduced
velocity and/or force generation (Power = Force × Velocity) (Katsiaras et al., 2005;
Callahan & Kent-Braun, 2011; Kent-Braun et al., 2012). Older men and women fatigue
sooner and to a greater extent than their young counterparts during dynamic contractions
(Figure 2) (Hicks et al., 2001; Katsiaras et al., 2005; Callahan & Kent-Braun, 2011;
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Christie et al., 2011; Broxterman et al., 2017; Sundberg et al., 2018). Depressed whole
muscle function that characterizes fatigue in older adults has been associated with a
higher risk for falls (Wolfson et al., 1995; Schwendner et al., 1997) and increased frailty
(Theou et al., 2008), indicating reduced physical function (Figure 3) in a population that
is already experiencing whole body functional decline due to aging (Bassey et al., 1992;
Cuoco et al., 2004; J. Holmes et al., 2009). Older adults with reduced physical function
have a greater likelihood of being hospitalized (Cawthon et al., 2009), which increases
their physical and financial burden upon themselves and society overall. The impact of
these decrements with fatigue will be exacerbated by the growing population of people
aged 65 years and older that is projected to nearly double from 48 million in 2015 to 82
million by 2040 (Ortman et al., 2014). Therefore, skeletal muscle fatigue in older adults
is an important phenomenon to understand and counteract due to its detrimental
functional implications and increasing prevalence in the future.
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Figure 2. Dynamic skeletal muscle fatigue in young versus older adults. Changes
in normalized power over time in the quadriceps muscles of 11 young (dark circles)
and 10 older (open circles) activity-matched (sedentary) women in response to high
velocity maximal voluntary dynamic knee extensions (270°/sec) (P<0.01 young vs.
older). Reduced power characterizes fatigue. Adapted from (Callahan & Kent-Braun,
2011).
	
  

Figure 3. Effects of dynamic skeletal muscle fatigue in older adults. Blue boxes
indicate associations observed in the literature. Yellow boxes indicate hypothesized
relationships.
	
  

2.2.2 Rationale for Studying Cellular and Molecular Interactions
Although skeletal muscle contraction depends upon both neural and contractile
factors, fatigue primarily results from altered contractile properties. Contractile factors
account for up to 80% of fatigue in healthy young adults (Kent-Braun, 1999) and
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potentially even more in older adults since neural activation has not been shown to play a
significant role in muscle fatigue in this population (Kent-Braun et al., 2002). Thus, this
study focused on the effects of fatigue on the contractile components of skeletal muscle.
Whole body, skeletal muscle tissue and cellular performance are dictated in large
part by molecular-level myosin-actin cross-bridge interactions. The molecular level
interactions between myosin and actin largely determine single muscle fiber force and
velocity at the cellular level (Bottinelli, 2001; Miller et al., 2013). Single fiber type and
function largely influence whole muscle force and velocity (Harridge et al., 1996;
D'Antona et al., 2006; Miller et al., 2013), which have been shown to significantly dictate
physical function at the whole body level (Figure 4) (Manini & Clark, 2012; Reid &
Fielding, 2012). Therefore, studying the molecular and cellular mechanisms of altered
skeletal muscle contraction is vital to understanding changes in performance at higher
anatomical levels, such as fatigue. Studying the mechanisms of fatigue will deepen our
understanding of this phenomenon and help provide the foundation to develop potential
molecular-based treatments to counteract fatigue-related declines in muscle function,
leading to improved physical function. These advancements are especially important for
older adults who are most vulnerable to the detrimental physical effects of fatigue.
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Figure 4. Anatomical levels of skeletal muscle function. Myosin-actin interactions at
the molecular level dictate single fiber (cellular) function, which largely determines
whole muscle function. Whole muscle performance is a major determinant of whole
body function.

2.2.3 Biochemical Changes In Vivo
Under non-fatiguing conditions, when adenosine triphosphate (ATP) is
hydrolyzed to provide energy for the muscle cell, adenosine diphosphate (ADP) and
inorganic phosphate (Pi) are produced. Our body’s energy systems resynthesize ATP with
ADP and Pi and, when energy production and energy usage are in balance, metabolite
and substrate concentrations are maintained at concentrations of 5-8 mM ATP
(Kushmerick et al., 1992), 8-11 µM ADP (Kushmerick et al., 1992) and 4-5 mM Pi
(Pathare et al., 2005; Kemp et al., 2007). When these metabolic processes are quickened
during continuous and/or higher intensity fatiguing contractions, the build-up of products
exceeds the rate that ATP is resynthesized, leading to increased levels of ADP (≤ 200300 µM) (Chase & Kushmerick, 1995) and Pi (30 mM) (Dawson et al., 1978; Wilson et
al., 1988; Cady et al., 1989) as well as reduced levels of ATP (3 mM) (Sahlin et al., 1989)
(Table 1). Increased contractile activity also leads to a greater reliance on glycolytic
metabolism and therefore a build-up of hydrogen/acid (H+), characterized by a reduction
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in intramuscular pH from 7 (rest) to as low as 6.2 (fatigue) (Table 1) (Hermansen &
Osnes, 1972; Metzger & Fitts, 1987; Cady et al., 1989; Broxterman et al., 2017).

Baseline
Change w/
fatigue
Max/min
w/ fatigue
Time to
max/min
Stim. Freq.

Pi

pH

ADP

ATP

ROS,
RNS

[Ca2+]

4 -5 m M

7

8-11 µM

5-8
mM

-

pCa 4.5 or
greater

↑

↓

↑

↓	
  

↑	
  

↑/↓	
  

30 -40
mM

6.8-6.2

≤ 200-300
µM

3 mM

-

pCa 5.3-5.9

2-3 m i n

2-3 m i n

-

-

-

Fast: 2 min
Slow: 8 min

10 -26 H z

10 -26
Hz

-

-

-

20-83 Hz

Table 1. Changes in muscle intracellular milieu with fatigue. Arrows illustrate
direction of change with fatigue (↑ = increase, ↓ = decrease). Includes baseline (rest)
concentrations, maximum/minimum metabolite concentrations with fatigue, time (in
minutes) to reach maximal/minimal concentrations for each metabolite when fatigue is
induced via voluntary whole muscle contraction (Pi, pH, ADP, ATP) or electrical
stimulation in fibers (ADP, ATP, ROS/RNS, [Ca2+]) at specified stimulation
frequencies. Bold text indicates metabolites hypothesized to most affect contractile
function. Pi = inorganic phosphate, pH = potential of hydrogen (inversely related to H+),
ADP = adenosine diphosphate, [Ca2+] = peak transient calcium concentration, ROS,
RNS = reactive oxygen and nitrogen species. For [Ca2+], data is separated by fast and
slow-contracting fibers. Data obtained from (Hermansen & Osnes, 1972; Dawson et al.,
1978; Metzger & Fitts, 1987; Wilson et al., 1988; Cady et al., 1989; Sahlin et al., 1989;
Kushmerick et al., 1992; Chase & Kushmerick, 1995; Pathare et al., 2005; Kemp et al.,
2007; Broxterman et al., 2017).
	
  

Much of the cellular and molecular literature suggests that fatigue is mainly due
to elevated Pi and H+, while other substrate changes with fatigue in vivo play a more
minimal role. Single fiber and isolated myosin and actin protein studies have shown that
increased concentrations of Pi and H+ inhibit the myosin-actin cross-bridge and/or
myofilament protein activation (Allen et al., 2008; Fitts, 2008; Debold et al., 2016).
During fatiguing exercise in the quadriceps (Broxterman et al., 2017) and dorsiflexors
(Kent-Braun et al., 2002) of young and older men and women, a rise in Pi and lowering
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of pH correlate temporally with reduced whole muscle force (Figure 5), which provides
in vivo evidence that changes in Pi and pH are linked to fatigue. Other metabolites and
substrates besides Pi and H+ change during fatigue (Table 1), though most are presumed
to play a minimal role in decreased muscle performance and/or are not easily measured
with current techniques. Single fiber evidence suggests that concentrations of ADP (8-11
µM to ≤ 200-300 µM) (Chase & Kushmerick, 1995) and ATP (5-8 mM to ≥ 3 mM)
(Sahlin et al., 1989) do not change enough to significantly affect contractile function at
the cellular and molecular levels (Cooke, 2007). Reactive oxygen and nitrogen species
(ROS and RNS) may also increase and contribute to fatigue, but measurements of ROS
and RNS concentrations are difficult to quantify, making their exact contributions to
fatigue unknown (Cooke, 2007; Westerblad & Allen, 2011; Debold et al., 2016).
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Figure 5. Changes in force, inorganic phosphate (Pi) and H+ (pH) during fatigue.
Changes in peak force, Pi and pH over time in the quadriceps muscles in 8 young men
fatigued with 5 minutes of all-out, intermittent maximal isometric single leg knee
extensions (3-s contraction, 2-s relaxation). Metabolite concentrations were measured
using magnetic resonance spectroscopy. Adapted from (Broxterman et al., 2017).
	
  

Studies that have electrically stimulated single fibers from frogs have shown that
peak transient calcium concentration ([Ca2+]) first increases from resting levels (pCa 8,
where pCa = log10[Ca2+]) to maximal activation (pCa 4.5), but then falls to submaximal
levels (pCa 5.3-5.9) during fatigue (Table 1) (Allen et al., 1989; Westerblad et al., 1989;
Lee et al., 1991). Reduced [Ca2+] can impair cross-bridge function and therefore decrease
fiber force and velocity. For example, fibers exposed to high Pi and low pH conditions
exhibited greater force reductions when activated at lower [Ca2+] (pCa 5.3-5.9) than at
maximally activated [Ca2+] (Nelson & Fitts, 2014; Debold, 2016).
However, reduced [Ca2+] with fatigue may not contribute to decrements in crossbridge function as much as elevated Pi and low pH. During fatiguing contractions, Pi and
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H+ begin to rise first (within < 1 min of starting contractions) before reaching their
maximum within 2-3 minutes (Kent-Braun et al., 2002; Broxterman et al., 2017), whereas
single fiber data suggests that [Ca2+] increases during the first minute or so then steadily
decreases mainly during long duration fatigue (Allen et al., 1989; Westerblad et al., 1989;
Lee et al., 1991). In addition, stimulation frequency differs between single fiber and
whole muscle fatigue studies and may significantly affect [Ca2+]. In single fibers fatigued
with electrical stimulation, the stimulation frequency starts at 20 Hz and ramps up to a
maximum of 83 Hz (Allen et al., 1989; Westerblad et al., 1989; Lee et al., 1991). In
quadriceps muscles of young and older men, stimulation frequency measured with
electromyogram (EMG) was 10-20 Hz when 75% of the motor units discharged and 26
Hz during maximum voluntary contraction (MVC) (Roos et al., 1999). These data
suggest that [Ca2+] may not immediately decrease enough to account for the large
decrements in cross-bridge function during the first few minutes of contractions.
Furthermore, fatigued single fibers are stimulated at a greater intensity (up to 83 Hz) than
what occurs in vivo (10-26 Hz), suggesting that [Ca2+] may decline less and at a slower
rate in vivo compared to electrically stimulated fibers. These hypotheses still need to be
confirmed, however, because no studies have measured in vivo [Ca2+] in human skeletal
muscle. In conclusion, although reduced [Ca2+] may contribute to fatigue, the effects of
elevated Pi and H+ on myosin-actin cross-bridge function may be the most important
alterations to examine during fatigue and were therefore the focus of this study.	
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2.3 Overview of Skeletal Muscle Contraction
2.3.1 The Cross-bridge Cycle
According to the sliding filament theory, contraction occurs when the head of the
myosin filament binds to and causes the actin filament to slide past myosin and shorten
(contract) the sarcomere (H. E. Huxley, 1969). This model has been the predominant
theory for over 50 years due to strong structural, physiological and biochemical
supporting data (K. C. Holmes & Geeves, 2000). Myosin hydrolyzes ATP into ADP and
Pi to re-cock its head (the cross-bridge) (Figure 6, step 1) to the starting position in
preparation for binding to actin (Lymn & Taylor, 1971; Steffen et al., 2003). Once Ca2+
makes the binding sites on actin available, myosin can weakly bind to actin (Figure 6,
step 2). Either prior to or immediately after myosin strongly binds to actin, myosin
releases inorganic phosphate (Pi) (Figure 6, step 3), generates force and goes through the
powerstroke (Lymn & Taylor, 1971; Takagi et al., 2004). During the powerstroke, the
myosin head undergoes a conformational change and pulls the actin filament, causing the
actin filament to slide past the myosin filament. Next, the myosin-actin cross-bridge
releases adenosine diphosphate (ADP) (Figure 6, step 4) and completes the second,
smaller conformational change of the powerstroke (Takagi et al., 2004). After the
powerstroke is complete, a new ATP molecule binds to the myosin head (Figure 6, step
5), causing it to dissociate from actin (Lymn & Taylor, 1971). These steps are
collectively known as the cross-bridge cycle and ultimately result in muscle contraction
when performed ensemble by millions of myosin heads across many fibers throughout
each whole muscle. Importantly, specific steps of the cross-bridge cycle can be altered
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and/or reversed under certain conditions, such as when the putative agents of fatigue are
elevated (Figure 6, gray arrows at each step).

Figure 6. Schematic representation of the cross-bridge cycle. The myosin head
(pink oval) interacts with the actin filament (string of white circles). The myosin head
is connected to its tail (pink cylindrical shape), which eventually is incorporated into
the thick filament (pink cylindrical shapes together). Steps 1-5 indicate one full crossbridge cycle. Black arrows represent a normal cross-bridge cycle; gray arrows indicate
steps in the cross-bridge cycle where metabolites/substrates can rebind to or dissociate
from the myosin head under certain conditions (e.g. high Pi and H+). Myosin-actin
cross-bridge kinetics measured in this study include the rate of myosin force
production (step 3, transition from weak to strong binding states) and myosin
attachment time (ton) (steps 3-5, strong binding state)).
	
  

2.3.2 The Cross-bridge Cycle Dictates Single Fiber Velocity and Force
The cross-bridge cycle largely determines single fiber velocity and force or
tension (force/CSA). Fiber velocity is mainly dictated by the amount of time that myosin
is strongly bound to actin, or myosin attachment time (ton) (Figure 6, steps 3-5), with
longer attachment times lengthening the cross-bridge cycle and therefore slowing fiber
velocity (Piazzesi et al., 2007; Miller et al., 2017). Single fiber force production occurs
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when myosin is strongly bound to actin (Figure 6, steps 3-5) and undergoes the
powerstroke (Figure 6, step 3). Fiber force is determined by the number of myosin heads
strongly bound to actin multiplied by the force exerted by each head (A. F. Huxley, 1957;
Brenner, 1988; Linari et al., 2004), which is generated during the powerstroke. Hence,
increasing the number of strongly bound heads and/or the force exerted per myosin head
will increase fiber force. The number of myosin heads strongly bound to actin is
influenced by the two components of total cross-bridge cycle time, myosin attachment
time (ton; Figure 6, steps 3-5) and myosin detachment time (toff; Figure 6, steps 5-2).
When ton alone is lengthened, the overall amount of time myosin remains strongly bound
compared to the total cycle time, or its duty ratio [ ton / (ton + toff) ], is increased. In a
population of myosin, an increase in the duty ratio leads to more strongly bound myosin
heads at any given time and an increase in fiber force (Linari et al., 2004). When toff alone
is lengthened, the duty ratio is decreased, fewer heads are strongly bound at any given
time, and fiber force is decreased. The rate of myosin force production (Figure 6, step 3),
or the sum of the forward and reverse rate constants of this step, and ton can be measured
using our small amplitude sinusoidal oscillations. A decrease in the myosin rate of force
production typically occurs due to a decrease in the forward rate constant, causing toff to
become longer, fewer myosin heads to be strongly bound, and fiber force production to
decrease.
Overall, slower cross-bridge kinetics, meaning longer ton and toff, will decrease
single fiber velocity due to the inverse relationship between velocity and ton. However,
alterations in force depend upon the relative changes in ton and toff. If ton increases to a
greater extent relative to the total cycle time, or an increased duty ratio, a greater number
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of myosin heads will be strongly bound at a given time and fiber force will increase. In
addition, an increase in the force exerted by each myosin cross-bridge could also increase
fiber force.

2.4 Skeletal Muscle Fatigue: Cellular and Molecular Contractile Alterations
Studies in single fibers (chemically skinned or mechanically peeled) and isolated
myosin and actin molecules (laser trap and in vitro motility experiments) using young
animal models and one human model have enhanced our understanding about how the
putative agents of fatigue (Pi and H+) may compromise the ability of myosin and actin to
generate velocity, force and power (Debold et al., 2012; Debold et al., 2013; Nelson et
al., 2014; Debold et al., 2016; Sundberg et al., 2018; Woodward & Debold, 2018).
Because concomitant changes in Pi and pH have been linked to fatigue in vivo and both
metabolites are known to inhibit myosin-actin cross-bridge function, this literature review
will primarily focus on studies that have examined the combined effects of elevated Pi
and H+. This review will also focus on fatigue research conducted at near-physiological
temperatures (25°C or higher) since this is most applicable to in vivo conditions (37°C) as
studies have shown that single fiber contractile properties and alterations with elevated Pi
and H+ are temperature dependent. Older studies traditionally examined fibers at colder
temperatures (10-15°C) to maintain sarcomere integrity (Cooke et al., 1988; Metzger &
Moss, 1990), leading to artificial differences in fiber function due to temperature because
certain aspects of the cross-bridge cycle become slower as temperature decreases (Pate et
al., 1995). Relatively recent advancements now provide the ability to quickly change
solution temperatures, which helps maintain sarcomere integrity and enables single fiber
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experiments to be performed at near-physiological temperatures (25-30°C in vitro vs.
37°C in vivo) (Pate et al., 1995; Miller et al., 2010; Nelson et al., 2014). Single fiber
studies that simulated fatigue with isolated metabolites and at colder temperatures will
also be briefly discussed in order to provide a complete picture of the cellular and
molecular fatigue literature.
Few cellular and molecular studies have used conditions that closely mimic
fatigue in vivo with elevated Pi (5 to 30 mM) and low pH (7 to 6.2) at near-physiological
temperatures (25-30°C in vitro vs. 37°C in vivo). Furthermore, most of these studies have
used young animal tissue and only one study has been performed in single fibers from
young and older men. This is important since human fibers have different underlying
properties than animal fibers such as slower cross-bridge kinetics because cross-bridge
kinetics tend to slow as the species become larger (Pellegrino et al., 2003). In addition,
women are more fatigue-resistant than men at submaximal, whole muscle contractions
(Hicks et al., 2001; Labarbera et al., 2013) and older women tend to have slower crossbridge kinetics than older men when matched for physical activity (Miller et al., 2013),
suggesting that women have different underlying contractile properties than men with
age. Thus, although the animal studies presented in this review provide valuable insights,
performing experiments in human skeletal muscle tissue from men and women may be
necessary to understand human and sex-specific responses to fatigue. The following
sections will review current literature about how skeletal muscle function at lower
anatomical levels is altered with elevated Pi and/or low pH to simulate fatigue.
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2.4.1 Effects of Elevated Pi and H+ (low pH) on Contractile Function
Consistent with whole muscles, fatigue simulated with elevated Pi and low pH in
single fibers and isolated myosin and actin proteins depressed power production due to
declines in maximal velocity and force, which were largely due to inhibited myosin-actin
cross-bridge function (Table 2). Elevated Pi and H+ have synergistic effects on crossbridge function when examined in combination, indicating the importance of studying the
effects of these molecules together. The following sections will review the effects of
elevated Pi and low pH on single fiber force and the potential molecular mechanisms for
reduced force with high Pi and H+, since these were the focus of the present study. This
study focused on examining the mechanisms of reduced fiber force with high Pi and H+
because of discrepancies and uncertainty in the current literature.
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F ibe r
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-‐	
  

MHC I

-‐	
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-‐	
  

-‐	
  

-‐	
  

-‐	
  

-‐	
  

-‐	
  

MHC I
MHC II
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+

+

Table 2. Effects of high Pi and/or low pH on single fiber and isolated protein
function. Most animal experiments examined tissue from young rat, rabbit (single
fibers) or chicken pectoralis+ (isolated proteins; mainly type II muscle (Verdiglione &
Cassandro, 2013)) studied at 30°C with low pH (6.2-6.5) and/or high Pi (10-30 mM).
Arrows indicate direction of change (↓ = decrease, ↔ = no significant difference)
and percent change (↓ = 10-20%; ↓↓ = 21-40%; ↓↓↓ = 41-60%; ↓↓↓↓ ≥ 60%)
compared to control, non-fatigue conditions (Pi 0-5 mM; pH 7-7.4) with results from
studies separated by a comma (,). Data are separated by fiber type into slow- (myosin
heavy chain (MHC) I) and fast- (MHC II) contracting fibers. Animal single fiber data
was obtained from ((Debold et al., 2004; Debold et al., 2006; Karatzaferi et al., 2008;
Knuth et al., 2006; Nelson et al., 2014). Human single fiber data was obtained from
(Sundberg et al., 2018), where all MHC II data was obtained at 15°C. Isolated protein
data was obtained from (Debold et al., 2008; Debold et al., 2011; Debold et al., 2012;
Debold et al., 2013; Woodward & Debold, 2018).
	
  

2.4.1.1 Single Fiber Force
Most recent studies have shown that simulating fatigue with both elevated Pi (30
mM) and low pH (6.2) at temperatures close to in vivo (30°C in vitro vs. 37°C in vivo)
depressed single fiber peak force and therefore tension (force/CSA). The most recent
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study in young and older men showed that high Pi and H+ reduced peak force in MHC I
(21-22%) and II (40-43% at 15°C) fibers (Sundberg et al., 2018), which was less than
what was observed in rat fibers (MHC I: 36%; MHC II: 46%) (Nelson et al., 2014) and
rabbit psoas fibers (52% for MHC I and II combined) under similar conditions (Table 2)
(Karatzaferi et al., 2008). Elevated Pi and H+ also depressed the fiber force-velocity
relationship (Nelson et al., 2014; Sundberg et al., 2018), indicating that submaximal force
declined across the entire range of velocities. Other studies in young animal fibers that
examined elevated Pi (S. Palmer & Kentish, 1994; Coupland et al., 2001; Debold et al.,
2004; Debold et al., 2006; Nelson et al., 2014) or low pH (S. Palmer & Kentish, 1994;
Pate et al., 1995; Pedersen et al., 2004; Kristensen et al., 2005; Knuth et al., 2006; Nelson
et al., 2014) individually at high temperatures observed decreased peak fiber force
compared to control conditions, but to a lesser extent than studies simulating fatigue with
high Pi and low pH combined. These data suggest that both Pi and pH decrease maximal
fiber force, therefore Pi and pH must individually inhibit myosin-actin cross-bridge
function. Some evidence suggests that the combination of elevated Pi and H+ may reduce
force in a synergistic manner (Chase & Kushmerick, 1988; Cooke et al., 1988; Potma et
al., 1995), reinforcing the importance of simulating fatigue with both metabolites
combined because both Pi and pH change concurrently with fatigue in vivo.
Single fiber fatigue studies in young animal tissue conducted at relatively low
temperatures (10-15°C) with high Pi and low pH combined (Cooke et al., 1988;
Karatzaferi et al., 2008; Nelson et al., 2014), high Pi only (Cooke et al., 1988; Martyn &
Gordon, 1992; Wahr et al., 1997; Coupland et al., 2001; Debold et al., 2004; Debold et
al., 2006; Caremani et al., 2008; Nelson et al., 2014; Caremani et al., 2015) and low pH
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only (Chase & Kushmerick, 1988; Cooke et al., 1988; Metzger & Moss, 1990; Pate et al.,
1995; Westerblad et al., 1997; Knuth et al., 2006; Nelson et al., 2014) showed greater
declines in peak force compared to fibers exposed to similar conditions at high
temperatures (25-30°C). Low temperatures introduced artificial differences in force due
to a greater slowing of the rate constant of myosin force generation, leading to fewer
strongly bound heads and reduced fiber force compared to high temperatures (Zhao &
Kawai, 1994; Galler & Hilber, 1998; Fitts, 2008). Therefore, although the decline in force
is less pronounced at high temperatures, studying fiber function at temperatures closer to
in vivo (37°C) is more physiologically relevant.

2.4.1.2 Myosin-actin Cross-bridge Function
Reductions in single fiber force may be the result of elevated Pi and H+ decreasing
the number of strongly bound cross-bridges and/or reducing the force exerted per crossbridge (Force = N*FCB, where N = number of strongly bound cross-bridges, FCB = force
per cross-bridge). Many studies have measured fiber stiffness in order to examine the
number and/or stiffness of bound myosin heads. However, measurement methods and
experimental results vary regarding the effects of high Pi and low pH on fiber stiffness
and there is currently no consensus. Most studies on fiber stiffness have only examined
the effects of elevated Pi or H+ in isolation. At low temperatures (10-12°C), low pH (6.2)
reduced stiffness in fast (MHC II) but not slow (MHC I) contracting fibers (Metzger &
Moss, 1990), while elevated Pi decreased stiffness in MHC II fibers (Caremani et al.,
2008), both of which indicate fewer strongly bound cross-bridges in MHC I but not MHC
II fibers. One recent study (Nelson et al., 2014) that examined the effect of high Pi and
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low pH on fiber stiffness (assumed to represent the total number of bound myosin heads)
at 30°C in young rodent fibers found that stiffness was not altered in MHC I or II fibers,
indicating no change in the number of bound heads. Since force was reduced with high Pi
and low pH but stiffness was unchanged, this implied that there was a reduction in the
force generated per cross-bridge. Another study that simulated fatigue in young mouse
fibers (primarily MHC II) at 22-24°C suggested that force was initially reduced due to
each cross-bridge generating less force, while greater force reductions over time occurred
due to a reduction in the number of strongly bound myosin heads (Nocella et al., 2011).
At the molecular level in isolated myosin-actin proteins, elevated Pi and low pH reduced
the number of strong binding events (fewer strongly bound myosin heads) (Woodward &
Debold, 2018), which provides direct evidence of the changes in myosin-actin crossbridges that can only be inferred about at the single fiber level. Overall, the effects of
high Pi and low pH on fiber stiffness and its components at high temperatures are
understudied and results are somewhat inconsistent. Stiffness measurements under high
Pi and H+ conditions have also not been performed in fibers from humans or older
populations, both of which are important for determining the mechanisms of fatigue and
the applicability of current simulated fatigue data to older adults.
The number of strongly bound myosin heads is largely dictated by myosin-actin
cross-bridge kinetics (ton and rate of myosin force production, which determines toff),
which can be altered by elevated Pi and H+. H+ is thought to slow the release of ADP
from myosin (Figure 6, step 4), which prolongs the strong binding state and therefore ton
as hypothesized by molecular studies using in vitro motility (Debold et al., 2008; Debold
et al., 2012). Longer ton decreases the rate at which myosin uses energy (ATPase) (Potma
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et al., 1995), which lengthens the total cross-bridge cycle time (ton + toff). In support of
this, a recent isolated protein study using the laser trap assay (Woodward & Debold,
2018) as well as earlier single fiber work (Cooke et al., 1988) have shown that ATPase
declines with high Pi and H+ combined, indicating longer ton and/or toff. However, earlier
work that separated myosin and actin proteins speculated that Pi is more likely to rebind
to the myosin head as H+ prolongs the strongly bound state (Figure 6, step 3), causing
myosin to dissociate from actin faster and shorten ton (Debold et al., 2011; Debold et al.,
2012; Longyear et al., 2014). This contradicts single fiber work showing that only high
H+ slows contractile velocity, whereas elevated Pi has no effect (Knuth et al., 2006;
Karatzaferi et al., 2008; Nelson et al., 2014) even when in combination with high H+
(Karatzaferi et al., 2008; Nelson et al., 2014; Sundberg et al., 2018), indicating that ton
either does not change or slows with high levels of Pi and/or H+. The effects of high Pi
and low pH on ton has only been hypothesized using results from in vitro motility and
laser trap assays in isolated myosin and actin proteins but not measured in single fibers
until the present study, which is important because of discrepancies between single fiber
and isolated protein results.
If ton slows with high Pi and low pH like single fiber and isolated protein studies
suggest, then the strongly bound state would be prolonged and increase the number of
strongly bound myosin heads, which would increase fiber force. Because previous
literature has consistently shown that fiber force declines with high Pi and H+ conditions,
myosin detachment time (toff) (the time when myosin heads are not strongly bound and
exerting force) must lengthen to a greater degree than ton to prolong the non-force
generating state. As the rate of myosin force production (Figure 6, step 3) slows, toff
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becomes longer, which leads to a reduction in the number of strongly bound, forceproducing myosin heads and a reduction in fiber force. A recent human single fiber study
showed that elevating both Pi and H+ reduced the rate that myosin transitions from weak
to strong binding measured by ktr (rate of force redevelopment) in both MHC I and II
fibers (Sundberg et al., 2018), which would prolong toff. An relatively older study in rat
fibers under the same conditions showed only a trend (P=0.07) towards a significant
decrease in ktr in MHC I fibers, but ultimately no significant change in either fiber type
with high Pi and H+ (Nelson et al., 2014). Lack of significance could have been due to
low fiber numbers (23 fibers total, averaging three MHC I and two MHC II fibers per rat
vs. 254 fibers total, averaging 4-10 fibers per person in the study by Sundberg et al.). One
isolated protein study (Debold et al., 2013) supported single fiber data by suggesting that
elevated Pi speeds up the reverse rate constant of the myosin head (Figure 6, step 3),
causing myosin to dissociate from actin shortly after initiating the strong binding state,
which shortens ton and may therefore increase toff (Chock, 1979). Molecular work also
suggests that high levels of H+ may inhibit the myosin forward rate constant (Figure 6,
step 3) (Debold et al., 2008), which would also lengthen toff (Figure 6, weak binding
state). Finally, a more recent isolated protein study found a reduction in strongly bound
cross-bridges with elevated Pi and H+, which they hypothesized was due to slower
myosin weak-to-strong binding and therefore longer toff (Woodward & Debold, 2018).
Overall, more work is needed to determine how cross-bridge kinetics are altered
with elevated Pi and H+ in human single fibers and how this reduces fiber force, which
has important implications for whole muscle and ultimately whole body function with
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fatigue. This study sought to address these gaps by examining the effects of elevated Pi
and H+ on molecular and cellular function in single fibers from older men and women.

2.5 dATP as a Potential Countermeasure for Skeletal Muscle Fatigue
This section will review basic evidence about using deoxyadenosine triphosphate
(dATP) as a potential countermeasure for fatigue simulated with high Pi and low pH and
future implications for treatment development to ultimately reverse fatigue-related
decrements in physical function.

2.5.1 What is dATP?
dATP is a nucleotide triphosphate (NTP) molecule, meaning that dATP is an
analog of ATP that serves as another form of energy because dATP is biologically similar
enough to ATP to be recognized as such (Figure 7) (Regnier et al., 1998; Regnier &
Homsher, 1998; Cid=15993.accessed Jan. 8, 2019; Cid=5957.accessed Jan. 8, 2019).
NTPs are valuable experimental tools since they are biologically recognized by the target
tissue but have slightly altered properties that make them useful for establishing
mechanistic and/or causative effects. For example, the mechanical behavior in NTPs can
be correlated with fluctuations in rate constants throughout different steps of NTP
hydrolysis to provide insights into mechanical and energetic aspects of muscle
contraction (Regnier et al., 1998; Regnier & Homsher, 1998). There are several NTPs
that occur naturally, including dATP, cyotosine triphosphate (CTP), deoxycyotosine
triphosphate (dCTP), uridine diphosphate (UTP), deoxyuridine diphosphate (dUTP),
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inosine 5’-triphosphate (ITP) and guanosine triphosphate (GTP). This review will focus
on dATP because evidence has revealed positive effects of dATP on single skeletal
muscle fiber function, which may help counter contractile declines such as those
observed with fatiguing conditions.

ATP	
  

dATP	
  

	
  

	
  

Figure 7. ATP and dATP structures. Chemical structures of adenosine triphosphate
(ATP) (left) and deoxyadenosine triphosphate (dATP) (right). The only structural
difference is that dATP has one less oxygen molecule than ATP, as indicated by the red
boxes. Adapted from PubChem Compound Database (Cid=15993.accessed Jan. 8, 2019;
Cid=5957.accessed Jan. 8, 2019).

2.5.2 dATP Improves Single Fiber Function and Possibly Simulated Fatigue
Few studies have examined the effects of dATP on skeletal muscle function, but
the results are promising. Regnier et al. demonstrated that, compared to single psoas
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fibers from young rabbits (primarily MHC II) (Hamalainen & Pette, 1993) using ATP as
their substrate, dATP was the only NTP that resulted in faster contractile velocity and
similar maximal force production due to similar fiber stiffness (Regnier et al., 1998;
Regnier & Homsher, 1998). All other naturally occurring analogs studied (CTP, dCTP,
UTP, dUTP, ITP and GTP) led to slower contractile velocity and/or less maximal force
than with ATP (Table 3). Fibers with dATP also exhibited a faster rate of energy
utilization (measured with NTPase, or the rate at which myosin uses energy to complete
the cross-bridge cycle) and force redevelopment (ktr) compared to ATP, indicating faster
kinetics. In cardiac tissue of various mammals, dATP enhanced both fiber velocity and
force compared to ATP (Regnier et al., 2000; Cheng et al., 2016; Thomson et al., 2016).
dATP leads to faster fiber velocity since dATP speeds up myosin detachment rate
(Figure 6, step 5) due to quicker dADP release from myosin (Regnier et al., 1998;
Regnier et al., 2000), indicating faster cross-bridge kinetics. dADP is able to release
quickly since it has a weaker affinity for myosin because of subtle structural differences
from ADP (Regnier et al., 1998; Regnier et al., 2000). The release of ADP from myosin
(Figure 6, step 4) is the step that limits unloaded velocity (Siemankowski et al., 1985;
Weiss et al., 2001; Nyitrai et al., 2006), most likely by altering myosin attachment time
(ton). Therefore, quicker release of dADP versus ADP could explain the faster fiber
velocity observed with dATP relative to ATP. In addition, faster hydrolysis of a
nucleotide triphosphate (NTP) may reduce toff (Koretz & Taylor, 1975; Chock, 1979) and
speed up cross-bridge kinetics. This hypothesis suggests that dATP speeds up the crossbridge cycle compared to ATP, resulting in faster cross-bridge kinetics and therefore
quicker single fiber contractile velocity.
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Maximal force

↔

Othe r N TPs v s. AT P
(n=6)
↓

Unloaded shortening velocity

↑

↓

Stiffness

↔	
  

↓	
  

NTPase

↑	
  

↓	
  

ktr

↑	
  

↑,	
  ↓	
  

dA T P v s. AT P

Table 3. Effects of NTPs on single fiber and isolated protein function. Adenosine
triphosphate (ATP) was substituted as an energy substrate with different nucleotide
triphosphates (NTPs) (dATP, CTP, dCTP, UTP, dUTP, ITP and GTP) in skinned,
single muscle fibers and isolated proteins from young rabbit psoas muscle. Arrows
indicate change with a particular NTP versus ATP (↔ = no significant difference, ↑
= increase, ↓ = decrease) with different results separated by commas (,). NTPase is an
enzymatic assay that measures energy utilization rate (rate of completing one crossbridge cycle) and ktr is rate of force redevelopment. (Regnier et al., 1998; Regnier &
Homsher, 1998).	
  
	
  

The benefits of dATP on improving single skeletal fiber function may be
applicable to fatiguing conditions. To date, Longyear et al. (2014) is the only study to
have examined the efficacy of dATP as a countermeasure for skeletal muscle contractile
decline with elevated Pi and low pH. Substituting ATP with dATP in isolated myosin and
actin proteins from young chicken pectoralis muscle placed in an in vitro motility assay
fatigued with high Pi (15 and 30 mM) and low pH (6.5) showed that peak velocity
(measured via actin filament velocity) was restored to control levels after being slowed
with high Pi and low pH (Figure 8) (Longyear et al., 2014). As described above, an
increased rate of dATP release from myosin (Regnier et al., 1998; Regnier et al., 2000)
most likely shortens ton and may speed up the rate of myosin force production, both of
which would quicken cross-bridge kinetics and therefore fiber velocity and possibly
increase fiber force under fatiguing conditions.
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Figure 8. Effect of elevated Pi and low pH with dATP in isolated proteins. In vitro
motility assay performed in isolated myosin and actin proteins from young chicken
pectoralis muscle. Peak actin filament velocity in non-fatigue (0 mM Pi, pH 7) (blue)
fatigue (15 & 30 mM Pi and pH 6.5) (red), and fatigue with dATP vs. ATP (green)
conditions. Adapted from (Longyear et al., 2014).
	
  

These data indicate that, in the future, dATP may be a viable treatment option to
reverse declines in skeletal muscle function observed with fatigue, though more evidence
is needed. Additionally, experiments should be conducted in older humans at higher
anatomical levels to determine the applicability of these molecular results to larger scale
function in older adults who are most burdened by fatigue. Further studies should
measure additional functional parameters at all anatomical levels to obtain a better
understanding about the molecular mechanisms and effects of dATP on mitigating and/or
reversing fatigue-induced decrements in cross-bridge kinetics and fiber force, velocity
and power, which are important determinants of whole muscle and physical function.
This study began to explore answers to these questions by examining changes in cellular
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and molecular function in response to dATP in single fibers from older men and women
under conditions simulating fatigue with high Pi and low pH.

2.5.3 Implementing dATP as a Treatment for Fatigue
In the future, dATP could be implemented as a treatment for fatigue-related
declines in skeletal muscle function. dATP is primarily involved with deoxyribose
nucleic acid (DNA) synthesis and tends to quickly convert to ATP (Thomson et al.,
2016), but a translational medicine technique can reverse this process and subsequently
increase levels of dATP in the body. One method of gene therapy, called BB-R12, directly
targets myosin and can up-regulate ribonucleotide reductase (R1R2), which is the ratelimiting enzyme in dATP synthesis in cardiomyocytes (Thomson et al., 2016). While this
technique targets cardiac contractility, similar techniques can theoretically be developed
and employed to up-regulate these same types of enzymes in skeletal muscle, thus
improving contractility and potentially reversing fatigue. Although these advancements
would take years to accomplish, a therapy for fatigue may be possible and worth
investigating in the future.

2.6 Summary
Skeletal muscle fatigue is characterized by functional decline at all anatomical
levels and is especially evident in older adults who fatigue sooner and to a greater extent
than young adults during dynamic muscle contractions. Fatigue decreases physical
function in older adults by increasing their risk for falls and becoming frail, thus
increasing likelihood of hospitalization and therefore personal and societal burden.
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Fatigue is a decrease in whole muscle velocity and/or force and therefore power (Power =
Force x Velocity) that occurs as a result of hard and/or continuous contractions. Fatigue
is temporally associated with elevated Pi and reduced pH in the muscle, indicating that
changes in these metabolites are linked to reduced muscle function with fatigue. Whole
muscle function is largely determined by single muscle fiber and molecular function,
which can be used to study the contractile mechanisms of fatigue in vitro by mimicking
in vivo conditions. Elevated Pi and low pH conditions lead to reductions in single fiber
velocity, force and power, though the molecular mechanisms for these declines are not
clear and sometimes inconsistent among single fiber and isolated myosin-actin protein
studies. All but one study to date have been performed in young animal tissue and may
not be applicable to older adults due to humans and older adults both having inherently
different contractile properties than animals and young adults, respectively. Furthermore,
the one human single fiber study was done in young and older men and studies have
shown that women may fatigue differently and have different underlying contractile
properties than men, especially with age. Finally, there are no treatments for fatigue
despite promising evidence that dATP can enhance single fiber velocity and maintain
force due to improved cross-bridge kinetics in normal conditions. Improved velocity also
occurred in high Pi and H+ conditions in isolated proteins. Understanding the mechanisms
of fatigue by studying single fibers from older men and women is important to ultimately
develop countermeasures for fatigue-related decrements in skeletal muscle function,
which will improve physical function and reduce personal and societal burden.
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CHAPTER 3
METHODS
3.1 Introduction
This study aimed to deepen our understanding about the mechanisms of skeletal
muscle fatigue in older adults and determine the efficacy of deoxyadenosine triphosphate
(dATP) as a potential treatment for the fatigue-induced decline in muscle function at the
cellular and molecular levels. Individual skinned skeletal muscle fibers from older men
and women were exposed to control (5 mM Pi (inorganic phosphate); pH 7), fatigue (30
mM Pi; pH 6.2) or fatigue with dATP instead of adenosine triphosphate (ATP) solutions.
In each condition, fiber tension (force/cross-sectional area) and myofilament mechanical
properties, including myosin-actin cross-bridge kinetics, were measured using small
amplitude sinusoidal analysis.

3.2 Participant Characteristics
3.2.1 Ethical Approval
Written, informed consent was obtained from each participant prior to being
enrolled in the study. Protocol approval was obtained from the Institutional Review
Board (IRB) at the University of Massachusetts, Amherst.
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3.2.2 Overview
This study used tissue taken under baseline/control conditions from another study
in our laboratory, the Cultivating Healthy Aging and Muscle Performance (CHAMP)
study. From this study, we obtained a sample of convenience by attaining tissue from the
first 8 sedentary, healthy older adults (4 men) who were recruited and functionally tested
214 fibers (104 slow- (type I) and 110 fast-contracting (type II); 26 per person on
average) single skeletal muscle fibers obtained via biopsy of the vastus lateralis for each
participant. Participant characteristics are outlined in further detail in Chapter 4: Results
(Table 4).
The following inclusion and exclusion criteria for our participants were obtained
directly from the CHAMP study:

3.2.3 Inclusion Criteria

•
•
•
•
•
•
•
•

Aged 65-75 years
Generally healthy, by self-report
Ambulatory without the use of walking aids
Living independently in the community
Non-smokers; for at least the preceding year
Relatively sedentary (no more than two 30-minute exercise sessions per week, by
self-report) verified by multilateral accelerometry using Actigraph
Women were postmenopausal, defined as cessation of menses for at least 12 months
prior to study
Must pass the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+)

3.2.4 Exclusion Criteria

•

History of major neurological or neuromuscular condition that may impact physical
function, including cerebrovascular disease, peripheral neuropathy,
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•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

•
•
•
•

neurodegenerative disease, demyelinating disease, cerebellar or extrapyramidal
disease, etc.
History of myocardial infarction, angina, peripheral vascular disease, surgical or
percutaneous coronary artery revascularization
History of severe pulmonary disease (i.e., dyspnea that limits activities of daily living
such as household ambulation and self-care)
History of rheumatoid arthritis
History of diabetes or other metabolic disease that may impact neuromuscular
function
Uncontrolled hypertension (blood pressure > 140/90)
History of smoking in the past 1 year
Moderate to severe lower extremity arthritis or pain (i.e., pain on level walking or that
limits activities of daily living such as household ambulation and self-care)
Pain, muscle cramps, joint stiffness, dyspnea, angina, light-headedness or other
symptoms upon exertion
The use of beta-blockers, sedatives, tranquilizers, or other medication that may impair
physical function
Individuals taking statin medications who report symptoms of muscle pain or
myopathy
Body-mass index >30 kg·m-2, as increased fat mass may alter single muscle fiber
performance
Body-mass index <18 kg·m-2, as this may be an early sign of frailty
Any persons taking anti-coagulant medication or with known coagulapathies will be
excluded, due to increased bleeding risk from biopsy procedure
Participants with a contraindication for magnetic resonance testing, including a pacemaker or other implant
Men and women undergoing hormone replacement therapy, because this treatment
may circumvent normal age-related declines in sex hormone levels (if taken, hormone
therapy must have been > 5 years ago)
Unintentional weight loss of greater than 2.5 kg during the last 3 months
Currently participating in or have participated in a weight loss or exercise training
program in the last year
An inability to understand written and spoken English
An inability to follow instructions, as determined by the investigators during the
consenting process
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3.3 Experimental Preparation
3.3.1 Location
All fiber preparation and functional analysis measures were completed in the Muscle
Biology Laboratory at University of Massachusetts, Amherst in Totman Physical
Education Building, room 140. The muscle biopsies were performed in an examination
room in the Human Testing Center at the Institute of Applied Life Sciences (IALS) at
University of Massachusetts, Amherst.

3.3.2 Muscle Tissue Processing
Muscle tissue processing has been described previously (Miller et al., 2010).
Biopsy tissue was placed immediately into cold (4°C) dissecting solution (in mM: 20
N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid (BES), 5 EGTA, 5 MgATP, 1 free
Mg2+, 1 dithiothreitol and 0.25 phosphate (Pi) with an ionic strength of 175 mEq, pH 7.0,
and at pCa 8 (pCa=−log10 [Ca2+]) for isolation of single ﬁbers for mechanical
measurements. Muscle fibers were processed for mechanical measurements by dissecting
the tissue sample into bundles of approximately 50+ fibers and tying each bundle to a
glass rod at a slightly stretched length at 4°C. Each tied bundle was then placed in
skinning solution (in mM: 170 potassium propionate, 10 imidazole, 5 EGTA, 2.5 MgCl2,
2.5 Na2H2ATP, 0.05 leupeptin and 0.05 antipain at pH 7.0) for 24 h at 4°C. After
skinning, fibers were placed in storage solution (identical to skinning solution, but
without leupeptin and antipain) with increasing concentration of glycerol (10% v/v
glycerol for 2 h, 25% v/v glycerol for 2 h) until reaching the ﬁnal storage solution (50%
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v/v glycerol), in which they were incubated at 4°C for 18–20 h. Thereafter, bundles were
stored at −20°C until isolation of single fibers for mechanical measurements, which
occurred within 4 weeks of the biopsy to ensure that there were no functional declines
due to prolonged storage.

3.3.3 Preparation of Single Fibers for Mechanical Analysis
Single fiber preparation has been described previously (Miller et al., 2010).
Muscle bundles were incubated in dissection solution containing 1% Triton X-100 (v/v)
for 30-40 min at 4°C. Segments (∼2.0-2.5 mm) of single fibers were manually isolated
from muscle bundles, aluminum T-clips placed at both ends of the fiber, and the fiber
was mounted onto hooks in dissecting solution at room temperature on the cross-sectional
area/fixation rig. Top and side diameter measurements were made at three positions along
the length of the middle 1-2 mm of the fiber using a ﬁlar eyepiece micrometer (Lasico,
Los Angeles, CA, USA) and a right-angled, mirrored prism to calculate average crosssectional area. Fibers were then ﬁxed at two points approximately 1-2 mm apart with
glutaraldehyde, as described elsewhere (Chase & Kushmerick, 1988; Hilber & Galler,
1998), with some modiﬁcations. Fixation was necessary to ensure that the fiber did not
tear during activation since this tends to occur in human fibers at elevated temperatures
(Miller et al., unpublished observations). Brieﬂy, fibers were placed in rigor solution (in
mM: 134 potassium propionate, 10 imidazole, 7.5 EDTA and 2.5 EGTA; 5 2,3butanedione monoxime at pH 6.8) and glutaraldehyde ﬁxative (~0.01% bromophenol
blue (v/v), 30% glycerol (v/v), 2% glutaraldehyde (v/v)) was applied (20 s per end) using
the gravity feed method (Hilber & Galler, 1998). The fiber was placed in dissecting
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solution with 1% bovine serum albumin to absorb any remaining glutaraldehyde and stop
it from spreading further along the fiber (Chase & Kushmerick, 1988). New T-clips were
placed on the ﬁxed regions, which were evident because of bromophenol blue indicator
dye. Any fiber remaining outside of the ﬁxed regions was cut off along with the original
T-clips. The fiber was incubated in dissecting solution containing 1% Triton X-100 (v/v)
for 30 min at 4°C to ensure removal of the sarcolemma and sarcoplasmic reticulum,
which allowed for control over the intracellular environment (e.g. contraction was
initiated with high [Ca2+] in order to measure fiber function).

3.3.4 Experimental Solutions
Constituents of all solutions used during mechanical measurements were
calculated using the equations and stability constants according to Godt & Lindley (Godt
& Lindley, 1982), as described previously (Miller et al., 2010). Relaxing solution was
dissecting solution with 15 mM creatine phosphate and 300 units/ml−1 of creatine
phosphokinase. Pre-activating solution was the same as relaxing solution, except at an
EGTA concentration of 0.5 mM. Control activating solution was the same as relaxing
solution, except at pCa 4.5, and Pi levels were 5 mM to correspond with resting Pi levels
in healthy human gastrocnemius (5 mM; (Pathare et al., 2005)) and quadriceps (4.5 mM;
(Kemp et al., 2007)) muscles, each comprised of both slow and fast fiber types. Single
fiber work in mouse and rat tissue demonstrated that [Pi] tends to be higher in type I and
IIX fibers (6 mM) compared to IIA fibers (0.8 mM) (Kushmerick et al., 1992), indicating
that the [Pi] used in this study may not be representative of exact in vivo values for each
specific fiber type, but instead were a good estimate. Furthermore, fiber type was
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determined after fiber measurements were obtained, so resting [Pi] could not have been
varied by fiber type. All solutions had an ionic strength of 175 mEq using sodium
methane sulfate. Fatigue activating solution was the same as control activating solution
except that Pi levels were increased to 30 mM and pH was lowered to 6.2 to simulate the
highest in vivo metabolite levels in fatigued whole muscle (Hermansen & Osnes, 1972;
Metzger & Fitts, 1987; Cady et al., 1989; Broxterman et al., 2017). Fatigue with dATP
activating solution was the same as fatigue solution except that 5 mM ATP was replaced
with 5 mM dATP.

3.4 Experimental Protocol
The experimental protocol is outlined below and in Figure 9. First, each fiber was
tested for maximal tension production in each of the three experimental conditions in a
random order with minimal time (< 5 seconds) between each trial: Control (5 mM Pi, pH
7, 5 mM ATP), fatigue (30 mM Pi, pH 6.2, 5 mM ATP), and fatigue with dATP (30 mM
Pi, pH 6.2, 5 mM dATP) (Figure 9). Second, myofilament mechanical properties,
including myosin-actin cross-bridge kinetics, were measured using small amplitude
sinusoidal analysis in all three conditions. Each sinusoidal analysis trial took ~5 minutes
with ~2 minutes between each trial. Each fiber went through all three experimental
conditions for tension measures, then was tested in two of the three experimental
conditions for sinusoidal analysis. It was not possible for each fiber to undergo sinusoidal
analysis testing in three conditions because there is generally considerable rundown by
the third trial, meaning that fiber function would be artificially reduced (Muscle Biology
Laboratory, unpublished observations).
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Figure 9. Overview of experimental protocol. Parameters measured with
corresponding techniques at single fiber and molecular levels under three
experimental conditions. Cross-bridge kinetics include myosin attachment time (ton)
and rate of myosin force production (derived from 2πb). Pi = inorganic phosphate,
ATP = adenosine triphosphate, dATP = deoxyadenosine triphosphate.
	
  

3.4.1 Single Fiber Mechanical Analysis
Single muscle fiber mechanical analysis was adapted from (Miller et al., 2010).
The T-clipped ends of the fiber were attached to a piezoelectric motor (Physik
Instrumente, Auburn, MA, USA) and a strain gauge (SensorNor, Horten, Norway) on the
sinusoidal analysis rig (Figure 10) in relaxing solution at 15°C to maintain fiber integrity,
and the fiber was manually stretched until the sarcomere length was set to 2.65 µm
(IonOptix, Milton, MA, USA) since this resembles in vivo sarcomere length in human
skeletal muscle (Chen et al., 2016). A camera (Point Grey, FLIR Integrated Imaging
Solutions, Inc., Richmond, BC, Canada) was used to image the fiber and a computer
program (ImageJ) performed a fast-fourier transformation (FFT) of the visible light and
dark sarcomere patterns to determine sarcomere length. The length of the fiber was
measured using a micrometer to determine the distance between the inside edges of the
T-clips on each end of the fiber. Fiber top width was measured in the middle of the fiber
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once it was stretched and side width was estimated using the ratio of the side/top widths
obtained on the cross-sectional area/fixation rig. Fiber top and estimated side widths were
used to normalize fiber force to cross-sectional area (CSA) and obtain tension
(force/CSA).

Figure 10. Sinusoidal analysis rig. Right: Top view of sinusoidal analysis rig. Left:
Magnified view of single muscle fiber with T clipped ends mounted on hooks
connected to the force gauge (top) and length motor (bottom).
	
  

Sinusoidal length perturbations and isometric tension measurements were
performed under maximal Ca2+-activation (pCa 4.5) at 25°C for control and fatigue
conditions as this approaches in vivo temperature (37°C) without compromising
sarcomere integrity; for example, researchers have reported difficulty obtaining data for
human MHC II fibers at 30°C (Sundberg et al., 2018). Furthermore, studies suggest that
25°C is a reasonable representation of in vivo temperature regarding force and rate of
force development since these parameters are much less temperature dependent between
25 and 37°C compared to colder temperatures (Ranatunga & Wylie, 1983; Bottinelli et
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al., 1996; Davis & Epstein, 2007). On the other hand, fiber velocity was shown to be very
temperature dependent between 12-22°C and above with a Q10 of 5.88 (Bottinelli et al.,
1996), suggesting that our cross-bridge kinetics measurements, which ultimately
determine fiber velocity, are also temperature dependent and would quicken at
temperatures higher than 25°C. Ultimately, 25°C was chosen as the experimental
temperature to provide a reasonable representation of in vivo conditions without
compromising fiber integrity.
Starting in relaxing solution at 15°C, the fiber was slackened completely, the
force gauge zeroed, the fiber pulled back to its original position, allowed to equilibrate
for 1 min and relaxed isometric tension measured. This process was known as setting the
tension baseline. The fiber was transferred to pre-activating solution for 30 s and then to
control activating solution, with tension recorded at its plateau. After tension plateau, the
fiber was returned to relaxing solution, given time to relax, and then stretched as
necessary so that sarcomere length was 2.65 µm. Starting again in relaxing solution,
temperature was increased to 25°C over the course of 1-2 min, tension baseline was set,
the fiber was transferred from pre-activating to control activating solution in the same
manner as before, and tension was recorded at its plateau. Tension plateau was obtained
and recorded in control (non-fatigue), fatigue, and fatigue with dATP conditions in a
randomized order. The fiber was then transferred back to relaxing solution to set
sarcomere length to 2.65 µm and tension baseline determined. Once force equilibrated,
the fiber was transferred from pre-activating to activating solutions using the same
protocol as described above. After recording the fiber’s tension at plateau, smallamplitude, sinusoidal length changes (0.05% of L) were applied to the fiber at 48
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frequencies (0.25 to 200 Hz) in control and fatigue conditions or in control and fatigue
with dATP conditions. Between each condition, sarcomere length was reset and tension
baseline determined. Length and force were normalized to determine fiber strain (ΔL/L)
and tension (force/CSA) by dividing the length change (ΔL) by L and by dividing the
force (F) by the fiber average cross-sectional area (CSA). Elastic (Ee) and viscous (Ev)
moduli (kNm−2) were calculated from the tension transient by determining the
magnitudes of the in-phase and out-of-phase components (0 deg and 90 deg with respect
to strain, respectively). The elastic and viscous moduli are the real and imaginary parts,
respectively, of the complex modulus, the ratio of the tension response to the strain.
To relate sinusoidal analysis with speciﬁc steps in the cross-bridge cycle, the
complex modulus at peak calcium activation was characterized by the following
mathematical expression (A):
Expression A: Y(ω) = A(iω/α)k − Biω/(2πb+iω) + Ciω/(2πc +iω),

where ω=2πf in s−1, A, B and C are magnitudes expressed in kNm−2, 2πb and 2πc are
characteristic rates expressed in s−1, i=−11/2, α=1s−1, and k is a unitless exponent. For
example, a Nyquist plot, or a plot of the viscous versus elastic modulus, for a human
MHC I skeletal muscle fiber from a heart failure patient was ﬁtted using the above
equation (Figure 11A) and broken down into its three processes (A, B and C). The Aprocess (described by parameters A and k) is a linear relationship between the viscous
and elastic moduli, while the B-process (described by parameters B and b) and C-process
(described by parameters C and c) are semi-circles (Figure 11B). These six parameters
have been related to various aspects of muscle mechanics through experimentation and
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modeling (Kawai et al., 1993; Zhao & Kawai, 1993; Mulieri et al., 2002; B. M. Palmer et
al., 2007). Although different models vary in their precise interpretation, the following
summarizes our laboratory’s current thoughts on the meaning of these parameters. The
A-process has no kinetic or enzymatic dependence (Q10 of ∼0.9; (Mulieri et al., 2002))
and reﬂects the viscoelastic properties of the structural elements of the fiber across the
oscillation frequency range. Under fully relaxed conditions, where no myosin heads are
attached, the A-process represents the viscoelastic properties of the underlying fiber
structure. Under Ca2+-activated conditions where myosin heads are attached, the Aprocess represents the underlying lattice structure, as well as a portion that increases with
Ca2+ concentration that is ascribed to the attached myosin heads (Mulieri et al., 2002; B.
M. Palmer et al., 2004). The parameter A indicates the magnitude of a viscoelastic
modulus and k represents the angle at which the A-process lies relative to the x-axis.
Thus, k reﬂects the viscous-to-elastic modulus relationship of the A-process. The
magnitude part of the B-process (B) is proportional to the number of myosin heads
strongly bound to actin and the cross-bridge stiffness (Kawai et al., 1993). The
characteristic rate of the B-process (2πb) is hypothesized to represent the apparent
(observed) rate of myosin force production or, in other words, the rate of myosin
transition between the weakly-and strongly bound states (Zhao & Kawai, 1993). For the
C-process, C is equivalent to the number of myosin heads strongly bound to actin
multiplied by the cross-bridge stiffness, and is therefore proportional to B, and (2πc)−1
represents the average myosin attachment time to actin, ton (B. M. Palmer et al., 2007).
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Figure 11. Six-parameter model used to ﬁt Nyquist plots from sinusoidal analysis. A,
the Nyquist plot of a Ca2+-activated (pCa 4.5) MHC I fiber, where each open circle
represents 1 of 48 oscillation frequencies (0.25 to 200 Hz) performed during sinusoidal
analysis, provides information on mechanical properties (elastic and viscous moduli) of a
muscle fiber and its components. Sinusoidal analysis results (open circles) are wellcharacterized by the continuous line, calculated using a six-parameter model (expression
A). The six model parameters can be related to cross-bridge function and myoﬁlament
structural properties and are paired into three different processes: the linear A-process
(continuous line, described by parameters A and k), the semicircular B-process (dash–dot
line, described by parameters B and b) and the C-process (dashed line, described by
parameters C and c). As a negative viscous modulus indicates positive work production,
the B-process is work producing and the A- and C-processes are work absorbing. The B
and C parameters, displayed as arrows the length of the diameter of the semicircular Band C-processes, are magnitudes (N mm−2) proportional to the number of strongly bound
cross-bridges and cross-bridge stiffness. The parameters b and c indicate the frequencies
(Hz) at which the B- and C-processes exhibit viscous modulus values that are the most
negative (or largest oscillatory work production) and positive (or largest oscillatory work
absorption), respectively. Importantly, 2πb and 2πc are characteristic rates (s−1) related to
cross-bridge kinetics, with (2πc)−1 being equivalent to myosin attachment time (ton). The
A-process represents the viscoelastic properties of the underlying lattice structure as well
as strongly bound cross-bridges. Parameter A, represented by an arrow, indicates a
magnitude (N mm−2) and k (a unitless exponent) is the angle at which the A-process lies
relative to the x-axis (Adapted from (Miller et al., 2010)).
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3.4.2 Fiber Typing
During all functional measurements, single fibers were typed as either type I or II
based on the speed of their kinetics; specifically, the rate of myosin force production
(2πb). Fibers were determined as type I if the viscous modulus dip, which is related to
2πb, occurred at < 2 Hz and as type II if the dip occurred at > 2 Hz; this method has been
fairly accurate for predicting fiber type relative to gel electrophoresis (Miller lab,
unpublished observations). This method cannot discern between hybrid fiber types, but
this analysis will be done with these data using gel electrophoresis in the near future to
determine the myosin heavy chain isoform of each fiber. Therefore, all fibers for these
analyses were categorized as either type I or II with no distinction of hybrids. Fibers that
had extremely fast (type II: dip > 5 Hz) cross-bridge kinetics were considered extreme
outliers and were excluded from this analysis (n=5 fibers) since these fibers are likely
hybrids or MHC IIX isoforms, potentially skewing the data. These outliers will be
reintegrated into the data after gel electrophoresis determines their isoforms. Other fibers
were also excluded for tension values that were abnormally low (< 60 mN/mm2) (n=4
fibers) or high (> 400 mN/mm2) (n=1 fiber), which often indicates a bad fiber or mix up
of top and side width for cross-sectional area calculations, respectively. 1 fiber was also
removed due to poor sinusoidal analysis data output that was unable to be fitted by
expression (A).
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3.5 Statistics
All data were reported as mean ± standard error of mean (S.E.M.) and differences
were considered significant at P ≤ 0.05. All variables were assessed for outliers within
each participant and by fiber type using boxplots of means and variability. Fibers that
appeared as outliers were reassessed to make sure that the fiber was functioning well
during testing per experimental notes as well as to make sure that the data output was
reasonable and fit properly with expression (A).
To determine the mechanisms of fatigue (Aim 1) and the ability of dATP to
reverse fatigue (Aim 2), differences in fiber tension as well as mechanics and kinetics
between control (5 mM Pi, pH 7, 5 mM ATP), fatigue (30 mM Pi, pH 6.2, 5 mM ATP)
and fatigue with dATP (30 mM Pi, pH 6.2, 5 mM dATP) conditions in type I and II fibers
were evaluated using a one-way analysis of variance (ANOVA) for each fiber type. A
linear mixed model was used with group assignment as the between-subject factor (i.e.
control group vs. fatigue group vs. fatigue with dATP group) as previously described
(Callahan et al., 2014). A linear mixed model was used because the general linear model
assumes that each measurement is independent, which is not the case for multiple fibers
evaluated within each participant (i.e. fibers from the same participant are related).
Accordingly, we have included a repeated effect in the model to account for variations in
fiber characteristics within each individual. By accounting for this within-subject
variance, this approach can be considered more conservative than the simple process of
taking an average value for each fiber characteristic for each subject, which yields a
single value for each individual with no estimate of variance. If a main effect was noted,
least significant difference post-hoc tests were performed to determine pairwise
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differences between the three experimental conditions. The additional between-subject
factor of sex was included in the same model in a second, separate analysis to evaluate
whether high Pi and H+ with ATP or dATP conditions had different effects on fiber
function in men and women. Least significant difference post-hoc tests were performed
for this secondary analysis as stated above. All analyses were conducted using IBM SPSS
Statistics for Windows version 25.0 (IBM, Armonk, NY) and SAS software version 9.4
(SAS Institute, Cary, NC).
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CHAPTER 4
RESULTS
4.1 Introduction
This study examined the effects of elevating two putative agents of fatigue, Pi and
H+ (low pH), and a potential countermeasure for fatigue, deoxyadenosine triphosphate
(dATP), on cellular and molecular function in single human skeletal muscle fibers from
older adults. We functionally tested 214 fibers (104 type I and 110 type II; 26 fibers per
person on average) from the vastus lateralis of 8 sedentary, healthy older adults (Table 4).
Overall, elevated Pi and H+ (simulated fatigue) reduced contractile function at the cellular
and molecular levels and activating the fiber with dATP versus adenosine triphosphate
(ATP) under the same conditions partially reversed these contractile deficits. There were
no experimental condition by sex effects in any of the parameters of cellular or molecular
function with high Pi and H+ for type I or II fibers (P>0.05 for all parameters, both fiber
types), indicating that tension, number of heads, cross-bridge kinetics and stiffness were
altered similarly in fibers from older men and women. Therefore, single fiber data from
men and women were analyzed together but separated by fiber type.
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M en

W om e n

T ot al

4

4

8

Ag e (y ear s)

70 ± 2.2

71 ± 1.7

71 ± 1.3

H ei ght (c m )

175 ± 3.0

153 ± 2.1*

164 ± 4.5

W ei ght (k g)

77.5 ± 1.7

58.8 ± 5.7*

68.1 ± 4.5

BM I (kg/m )

25.5 ± 1.1

25.2 ± 2.5

25.4 ± 1.3

M VP A (m i n/d ay )

18.7 ± 1.65

24.8 ± 3.6

21.8 ± 5.0

N

2

Table 4. Participant characteristics. Values represent variable means ± S.E.M.
*P<0.05 men vs. women.
	
  

4.2 Cellular and Molecular Changes in Response to Elevated Pi and H+ (low pH)
In single skeletal muscle fibers of older adults, maximal fiber tension (force/crosssectional area (CSA)) declined in both type I and II (23 and 28%, P<0.01 for both) fibers
under fatiguing conditions (elevated Pi (30 mM) and H+ (pH 6.2)) compared to control
conditions (5 mM Pi, pH 7) (Figure 12, left). High Pi and H+ reduced the number or
stiffness of strongly bound myosin heads (parameter C) in type I and II fibers (28% and
48%, P<0.01 for both) (Figure 12, right), leading to lower fiber tension.
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Figure 12. Tension and strongly bound myosin heads response to elevated Pi and
H+. Single fiber tension (force/CSA) and parameter C, the number of strongly bound
myosin heads, in type I and II fibers under control (5 mM Pi; pH 7) and fatigue (30
mM Pi; pH 6.2) conditions with maximal Ca2+ activation (pCa 4.5) at 25°C. Number
of fibers analyzed for Tension: Type I = 90 and II = 91; Parameter C: Type I = 93 and
II = 97. Significant pairwise differences indicated by **P<0.01 vs. control. Percent
change relative to control indicated by arrows above fatigue bars.
	
  

Fibers exposed high levels of Pi and low pH exhibited a slowing of cross-bridge
kinetics compared to control; ton (derived from 2πc) became longer in type I and II fibers
(40 and 18%, P<0.01 for both) (Figure 13, left) and the rate of myosin force production
(derived from 2πb) slowed in type I and II fibers (30 and 18%, P<0.01 for both) (Figure
13, right).
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Figure 13. Cross-bridge kinetics response to elevated Pi and H+. Myosin
attachment time (ton) (derived from 2πc) and rate of myosin force production (derived
from 2πb) in type I and II fibers under control (5 mM Pi; pH 7) and fatigue (30 mM Pi;
pH 6.2) conditions with maximal Ca2+ activation (pCa 4.5) at 25°C. Number of fibers
analyzed: Type I = 93 and II = 97. Significant pairwise differences indicated by
**P<0.01 vs. control. Percent change relative to control indicated by arrows above
fatigue bars.
Parameter A, or myofilament stiffness, represents the magnitude of the
viscoelasticity of the myofilament structure, including the number and force of strongly
bound cross-bridges. Elevated Pi and H+ caused type I fibers to become stiffer, as shown
by an increase in parameter A (48%, P<0.01), while type II fibers experienced no
significant change in stiffness (P=0.47) (Figure 14, left). Parameter k characterizes the
viscous-to-elastic relationship of parameter A, and represents the degree to which the
fiber is purely elastic (k=0) (behaves like a spring and does not absorb work) or viscous
(k=1) (behaves like a dashpot and absorbs work). Parameter k decreased with high Pi and
H+ in type I (24%, P<0.01) but not II (P=0.27) fibers (Figure 14, right), indicating that
type I fibers were becoming more elastic with high Pi and H+ and increases in parameter
A represented greater elasticity in both fiber types. The fact that fiber stiffness was
increased (type I) or unchanged (type II) with high Pi and H+ suggests that there was no
decrease in the stiffness of the strongly bound myosin heads (force per cross-bridge).
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Thus, the decrease in parameter C is interpreted as a decrease in the number of strongly
bound myosin heads, not a change in their stiffness.

Figure 14. Myofilament stiffness response to elevated Pi and H+. Parameter A, the
viscoelastic magnitude of the myofilament lattice with strongly bound cross-bridges
(greater values indicate greater stiffness) and parameter k, the degree to which the
fiber is purely elastic (k=0) or viscous (k=1), in type I and II fibers under control (5
mM Pi; pH 7) and fatigue (30 mM Pi; pH 6.2) conditions with maximal Ca2+ activation
(pCa 4.5) at 25°C. Number of fibers analyzed: Type I = 93 and II = 97. Significant
pairwise differences indicated by **P<0.01 vs. control. Percent change relative to
control indicated by arrows above fatigue bars.
Preliminary experiments using single fibers from 1 woman were performed to try
and determine the mechanisms of increased stiffness with elevated Pi and low pH in type
I fibers. When all cross-bridges were put into the weak-binding state using 80 mM 2,3butanedione monoxime (BDM) (10 fibers), fiber stiffness did not differ between high Pi
and H+ versus control conditions, suggesting that the myofilament lattice itself,
independent of strongly bound cross-bridges, did not stiffen. When all cross-bridges were
placed into the strong-binding state (rigor) in a 0 mM ATP solution with high Pi and H+
versus a 5 mM ATP control solution (11 fibers), there was still no increased stiffness.
Given these results, the reason for the increase in myofilament stiffness remains unclear.
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4.3 Cellular and Molecular Changes in Response to Elevated Pi and H+ (low pH)
with dATP
When muscle contracted with dATP instead of ATP, myosin-actin cross-bridge
kinetics recovered back to control levels or beyond in conditions with elevated Pi and low
pH (Figure 15). Myosin attachment time (ton) in high Pi and H+ conditions with dATP
recovered back to control levels in type I fibers (P=0.47 vs. control; 32%, P<0.01 vs.
fatigue) and exceeded control values for type II fibers (23%, P<0.01 vs. control; 35%,
P<0.01 vs. fatigue) (Figure 15, left). The rate of myosin force production in high Pi and
H+ conditions with dATP became faster than control values in type I (16%, P<0.01 vs.
control; 65%, P<0.01 vs. fatigue) and II (23%, P<0.01 vs. control; 50%, P<0.01 vs.
fatigue) fibers (Figure 15, right).

Figure 15. Cross-bridge kinetics response to elevated Pi and H+ with dATP.
Myosin attachment time (ton) (derived from 2πc) and rate of myosin force production
(derived from 2πb) in type I and II fibers under control (5 mM Pi; pH 7), fatigue (30
mM Pi; pH 6.2) and fatigue with dATP (30 mM Pi; pH 6.2; 5 mM dATP vs. ATP)
conditions with maximal Ca2+ activation (pCa 4.5) at 25°C. Number of fibers
analyzed: Type I = 93 and II = 97. Significant pairwise differences indicated by
**P<0.01 vs. control; ++P<0.01 vs. fatigue. Percent change relative to control indicated
by arrows above fatigue and fatigue with dATP bars.
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Although cross-bridge kinetics completely recovered back to or exceeded control
values in elevated Pi and low pH conditions with dATP versus ATP in both fiber types,
the number of strongly bound myosin heads and tension did not always recover to the
same degree (Figure 16). When ATP was replaced with dATP in high Pi and H+
conditions, the number of strongly bound heads fully recovered back to control values in
type I fibers (P=0.44 vs. control; 32%, P<0.01 vs. fatigue), while the number of heads
remained low and were not significantly different from values observed in high Pi and H+
conditions with ATP in type II fibers (46%, P<0.01 vs. control; P=0.79 vs. fatigue)
(Figure 16, right), suggesting a fiber-type-specific recovery. Although the number of
heads fully recovered in type I fibers, this only translated to a partial recovery of tension
relative to high Pi and H+ conditions with ATP (11%, P<0.01) as it was still lower than
control (15%, P<0.01) (Figure 16, left). Although the number of heads remained low in
high Pi and H+ conditions with dATP in type II fibers (Figure 16, right), tension was also
partially recovered relative to high Pi and H+ conditions with ATP (8%, P<0.05) but was
still lower than control (22%, P<0.01) (Figure 16, left), most likely due to large
improvements in cross-bridge kinetics with dATP versus ATP.
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Figure 16 Tension and strongly bound myosin heads response to elevated Pi and
H+ with dATP. Fiber tension and number of strongly bound myosin heads (parameter
C) in type I and II fibers under control (5 mM Pi; pH 7), fatigue (30 mM Pi; pH 6.2)
and fatigue with dATP (30 mM Pi; pH 6.2; 5 mM dATP vs. ATP) conditions with
maximal Ca2+ activation (pCa 4.5) at 25°C. Number of fibers analyzed for Tension:
Type I = 90 and II = 91; Parameter C: Type I = 93 and II = 97. Significant pairwise
differences indicated by **P<0.01 vs. control; +P<0.05 and ++P<0.01 vs. fatigue.
Percent change relative to control indicated by arrows above fatigue and fatigue with
dATP bars.

Compared to the control condition, the myofilament lattice of type I fibers
remained stiffer (larger parameter A) in elevated Pi and low pH conditions with dATP
(58%, P<0.01 vs. control) and was not significantly different than high Pi and H+ with
ATP (P=0.22) (Figure 17, left). On the other hand, the stiffness (parameter A) of type II
fibers remained unchanged in high Pi and H+ conditions with dATP compared to both
high Pi and H+ with ATP and control values (P=0.47) (Figure 17, left). In accordance
with parameter A, parameter k remained low relative to control values in type I fibers
exposed to high Pi and H+ conditions with dATP (23%, P<0.01) and was not significantly
different than high Pi and H+ with ATP (P=0.76), meaning that fibers became more
elastic in high Pi and H+ conditions and dATP did not further alter this parameter. In type
II fibers, k remained unchanged across all three experimental conditions (P=0.27) (Figure
17, right). Since k was closer to 0 (elastic) than 1 (viscous) for all experimental
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conditions in both fiber types, this indicated that parameter A represented the magnitude
of the fiber’s elasticity/stiffness. Overall, these data show that type I fibers from older
adults became stiffer and more elastic with high Pi and low pH while type II fibers
remained unchanged. Furthermore, substituting dATP for ATP in high Pi and H+
conditions had no effect on myofilament stiffness or elasticity in either fiber type.
	
  

Figure 17. Myofilament stiffness response to elevated Pi and H+ with dATP.
Parameter A, the viscoelastic magnitude of the myofilament lattice with strongly
bound cross-bridges (greater values indicate greater stiffness) and parameter k, the
degree to which the fiber is purely elastic (k=0) or viscous (k=1), in type I and II
fibers under control (5 mM Pi; pH 7), fatigue (30 mM Pi; pH 6.2) and fatigue with
dATP (30 mM Pi; pH 6.2; 5 mM dATP vs. ATP) conditions with maximal Ca2+
activation (pCa 4.5) at 25°C. Number of fibers analyzed: Type I = 93 and II = 97.
Significant pairwise differences indicated by **P<0.01 vs. control. Percent change
relative to control indicated by arrows above fatigue and fatigue with dATP bars.
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CHAPTER 5
DISCUSSION

5.1 Introduction
This study aimed to 1) determine the cellular and molecular mechanisms of
skeletal muscle fatigue by exposing single fibers from older adults to solutions with
elevated levels of the putative agents of fatigue and 2) evaluate the efficacy of
deoxyadenosine triphosphate (dATP) to reverse the negative effects caused by the
putative agents of fatigue. Fatigue was simulated in single skeletal muscle fibers in vitro
to closely mimic in vivo conditions by elevating inorganic phosphate (Pi) (from 5 to 30
mM) and H+ (lowering pH from 7 to 6.2). The results from this study are summarized
below in Figure 18. Elevated Pi and H+ decreased fiber tension (force/cross-sectional area
(CSA)) in type I and II fibers due to fewer strongly bound myosin heads caused by
slower cross-bridge kinetics (Figure 18). Elevated Pi and H+ with dATP instead of
adenosine triphosphate (ATP) recovered cross-bridge kinetics and the number of strongly
bound myosin heads in a fiber-type-specific manner, which led to partial recovery of
tension in both fiber types. Interestingly, myofilament stiffness increased in high Pi and
H+ conditions with ATP and dATP in type I fibers, but was unchanged in type II fibers in
all three experimental conditions. This study deepened our knowledge about the
mechanisms of skeletal muscle fatigue in human single fibers from older adults by
illustrating how high Pi and low pH conditions slowed cross-bridge kinetics, which
partially explained changes in maximal fiber tension. The present study also showed that
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the contractile deficits in cross-bridge kinetics and tension induced by high Pi and low pH
can be partially to fully reversed in these fibers.

Molecular level
(Myosin-actin)

Cross-bridge
kinetics

# of strongly bound
myosin heads

Aim 1

Aim 2

Fatigue vs. Control

Fatigue w/ dATP vs. Control

Type I
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Figure 18. Results summary. Summary of study results for Aims 1 & 2 by fiber type
(type I or II) at the molecular and cellular levels. Cross-bridge kinetics include myosin
attachment time (ton) (derived from 2πc) and rate of force production (derived from 2πb).
Parameter C is assumed to represent the # of strongly bound myosin heads. Experimental
conditions were the following: Control: 5 mM inorganic phosphate (Pi), pH 7, 5 mM
adenosine triphosphate (ATP); fatigue: 30 mM Pi, pH 6.2, 5 mM ATP; and fatigue with
deoxyadenosine triphosphate (dATP): 30 mM Pi pH 6.2, 5 mM dATP. Arrows indicate
direction of and percent change relative to control (increase: ↑	
  = 15-20%, ↑↑ = 2030%; decrease: ↓	
  =	
  15-20%,	
  ↓↓	
  = 20-30%, ↓↓↓	
  = ≥ 30%; no significant difference =
↔). This figure does not include parameters A and k (myofilament lattice stiffness)
because these were not primary measurements for the study aims.	
  
5.2 Aim 1: Cellular and Molecular Mechanisms in Response to High Pi and H+
(low pH)
Aim 1: Determine the effects of simulated fatigue on tension and myofilament
mechanical properties, including myosin-actin cross-bridge kinetics, in single fibers from
older men and women.
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Hypotheses for Aim 1: Simulated fatigue will 1A) decrease single fiber tension, due to
1B) a reduction in the number or stiffness of strongly bound myosin heads, and 1C)
slower cross-bridge kinetics, including increasing myosin attachment time (ton), in type I
and II fibers.

5.2.1 Mechanisms for Reduced Fiber Tension with High Pi and H+ (low pH)
Elevated Pi and low pH decreased maximal fiber tension (force/CSA) in type I
and II fibers, similar to what has been observed in previous studies that mimicked fatigue
with both high Pi (30 mM) and low pH (6.2) at high temperature (≥ 22°C) in fibers from
animals (Fitts, 2008; Karatzaferi et al., 2008; Nocella et al., 2011; Nelson et al., 2014)
and humans (Sundberg et al., 2018). High Pi and H+ decreased parameter C in type I and
II fibers, which represents a reduction in either the number or stiffness of strongly bound
myosin heads. If parameter C represented stiffness per cross-bridge, myofilament
stiffness (parameter A), or the stiffness of the myofilament lattice with strongly bound
cross-bridges, should have also decreased with high Pi and H+. Because parameter A
either increased (type I) or remained unchanged (type II) with elevated Pi and H+, this
suggested that the force exerted per cross-bridge (cross-bridge stiffness) was not reduced,
thus the decrease in parameter C most likely represented fewer strongly bound myosin
heads. Fiber force (and therefore tension) is the product of the number of strongly bound
myosin heads and force per head, so fewer strongly bound heads could account for the
decreased tension with elevated Pi and H+ observed in the present study. These data agree
with previous work suggesting that elevated Pi and H+ reduced the number of strongly
bound cross-bridges in fibers from animals (Nocella et al., 2011; Nelson et al., 2014) and
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humans (Sundberg et al., 2018) at high temperatures (≥ 22°C; 15°C for myosin heavy
chain (MHC) II human fibers), which was hypothesized to have been due to more weakly
bound cross-bridges (Nelson et al., 2014; Sundberg et al., 2018).
The number of strongly bound myosin heads and force per cross-bridge cannot be
directly determined or discerned in fiber experiments, so experiments in isolated myosinactin proteins using the laser trap assay provide useful information about individual
cross-bridge behavior. Using this technique at 30°C, elevating Pi only (30 mM) reduced
maximal force production of a myosin mini-ensemble (multiple myosin heads in series)
obtained from chicken pectoralis muscle (primary MHC II (Verdiglione & Cassandro,
2013)) due to fewer high force-generating myosin heads binding (Debold et al., 2013),
while acidosis only (high H+) reduced peak force by decreasing both the number of heads
strongly bound and the force generated per head (Woodward & Debold, 2018).
However, single fiber studies suggest that Pi and H+ synergistically depress force
(Chase & Kushmerick, 1988; Cooke et al., 1988; Potma et al., 1995; Nelson et al., 2014);
therefore these metabolites should be studied concurrently. One recent single molecule
and myosin mini-ensemble laser trap study at 30°C also using chicken pectoralis muscle
observed that elevated Pi (10 mM) and low pH (pH 6.5) combined also reduced peak
force (20%) to a similar degree as observed in the present study (23-28%) due to
elimination of all high-force binding events, which indicated that there were fewer
strongly bound myosin heads at any given time (Woodward & Debold, 2018). Overall,
isolated protein work using single molecules and myosin ensembles supports our
hypothesis that the reduction observed in parameter C with high Pi and low pH
represented fewer strongly bound myosin heads, which provides a mechanism for the
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reduction in fiber tension. Future isolated protein work could examine the effects of more
extreme metabolite concentrations (Pi 30 vs. 10 mM; pH 6.2 vs. 6.5) in both MHC I and
II muscle to clarify the applicability of these mechanisms to fatigue in vivo in different
fiber types.	
  

5.2.2 High Pi and H+ (low pH) Slowed Myosin-actin Cross-bridge Kinetics
The number of strongly bound myosin heads is largely dictated by myosin-actin
cross-bridge kinetics, specifically the duty ratio [ton/(ton + toff), where ton = myosin
attachment time and toff = myosin detachment time]. Elevating two putative agents of
fatigue (Pi and H+) in human skeletal muscle fibers from older adults slowed cross-bridge
kinetics by increasing ton, which contradicts research in myosin mini-ensembles with
elevated high Pi only (Debold et al., 2013) but agrees with work in single myosin
molecules in low pH only (Debold et al., 2008). However, recent isolated protein work
suggested that the combination of elevated Pi and low pH may still lengthen ton, but this is
most likely due to acidosis alone and is more pronounced at low pH only like in previous
studies (Woodward & Debold, 2018).
In the present study, high Pi and H+ conditions also slowed the other component
of cross-bridge kinetics, the rate of myosin force production. This agrees with previous
single fiber work where elevated Pi and H+ conditions slowed the rate of force
redevelopment measured with ktr (Fitts, 2008; Nelson et al., 2014; Sundberg et al., 2018),
which is a technique where the fiber is rapidly slacked and the rate of force recovery is fit
with a line. This technique is slightly different from the one used in the present study,
which measured the rate of force production (the sum of the forward and reverse rates of
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the myosin head) derived from parameter 2πb obtained during small amplitude sinusoidal
analysis. Therefore, the kinetics parameters obtained from these different techniques are
somewhat, but not completely similar. Isolated myosin-actin proteins exposed to elevated
Pi and low pH showed a reduction in the number of high force-generating events,
indicating fewer strongly bound myosin heads at a given moment due to a slower myosin
weak-to-strong binding transition (Woodward & Debold, 2018). The rate of force
development measured in the present study is thought to represent the rate of myosin’s
weak-to-strong binding transition, demonstrating that the isolated protein work supports
the current results.
Although this study did not quantify all components of the cross-bridge cycle, the
increase in ton observed with high Pi and H+ is hypothesized to have been countered by a
relatively larger increase in toff, which would increase the duty ratio and explain the
observed reduction in the number of strongly bound myosin heads. According to early
work in rabbit psoas fibers (Cooke et al., 1988), the time that myosin takes to complete
the cross-bridge cycle (ton + toff) measured with ATPase was slowed with high Pi and H+
compared to control conditions at low temperature (10°C) due to longer ton and/or toff.
Single molecule and myosin mini-ensemble data also showed reduced ATPase in solution
with both high Pi and low pH at 30°C, hypothesized to be largely the result of a slower
myosin weak-to-strong binding rate and thus longer toff (Woodward & Debold, 2018),
which supports the present hypothesis. The present study advanced our knowledge about
the molecular mechanisms of skeletal muscle fatigue, as it was the first to examine the
effects of high Pi and low pH on ton in single skeletal muscle fibers. This study also
quantified a new measurement of cross-bridge kinetics, myosin rate of force production,
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to further characterize changes in the cross-bridge cycle with high Pi and low pH. Future
work in our laboratory seeks to build upon the present study and quantify the entire crossbridge cycle in response to high Pi and H+ at high temperature (≥ 25°C) by measuring the
time to complete the total cross-bridge cycle (ton + toff) using an ATPase assay in
conjunction with measuring ton obtained from sinusoidal analysis. This will allow for
direct quantification of toff [(ton + toff) - ton] with high Pi and H+ to test the hypothesis that
toff increases under these conditions relative to control.

5.2.3 High Pi and H+ (low pH) Increased Myofilament Lattice Stiffness in Type I
Fibers
This was the first study to observe that myofilament lattice stiffness increased
with elevated Pi and low pH in type I fibers and did not change in type II fibers relative to
control despite decreased tension in both fiber types. Under normal conditions, increases
in parameter A have been associated with increased fiber tension (force/CSA) as a stiffer
lattice allows for greater force transmission (Miller et al., 2015). Prior research has shown
that high Pi and H+ reduced fiber stiffness (Nocella et al., 2011; Nelson et al., 2014),
contrary to the present study. However, these prior studies measured fiber stiffness by
oscillating the fiber at extremely high frequencies (2-4 kHz) in order to place all crossbridges in the strongly bound state, whereas stiffness measurements were obtained from
our fibers over a range of lower frequencies (0.25 to 200 Hz) where not all cross-bridges
were strongly bound at any given time. Perhaps the increased stiffness observed in the
present study highlights a compensatory mechanism to mitigate the decline in tension and
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fatigability that is characteristic of type I fibers, but the mechanisms of this phenomenon
are unknown.
Additional, preliminary experiments suggested that the myofilament lattice did
not become stiffer with or without strongly bound cross-bridges, thus the reason for
increased myofilament stiffness with high Pi and low pH in type I fibers remains unclear.
However, only 10 and 11 fibers of unknown types from 1 female participant each were
tested without any and with all strongly bound cross-bridges, respectively. Future
experiments that expose a greater number of type I and II human fibers to high Pi and H+
conditions with low ATP (rigor) or adenosine diphosphate (ADP) concentrations could
be used to verify whether parameter A increases due to greater force per cross-bridge, as
decreased [ATP] or [ADP] prolongs the strongly bound state (Debold et al., 2012;
Debold, 2012), which allows for manipulation of the number of cross-bridges in strong
binding. In addition to these future experiments, further analysis of the current data
should elucidate the possible mechanisms for increased parameter A with high Pi and H+
in type I fibers by parsing out how the elasticity and viscosity of this parameter are
altered under these conditions.

5.3 Aim 2: Efficacy of dATP to Reverse Contractile Decrements with High Pi and H+
(low pH)
Aim 2: Determine the ability of dATP to reverse simulated fatigue-induced changes in
tension and myofilament mechanical properties in single fibers from older men and
women.
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Hypotheses for Aim 2: Simulated fatigue with dATP will 2A) recover tension back to
control values, due to its ability to 2B) recover the number or stiffness of strongly bound
myosin heads and 2C) cross-bridge kinetics, in type I and II fibers.

5.3.1 High Pi and H+ (low pH) with dATP Recovered Myosin-actin Cross-bridge
Kinetics
Myosin-actin cross-bridge kinetics recovered when fibers were subjected to
elevated Pi and low pH conditions with dATP instead of ATP as an energy source. In
high Pi and H+ with dATP, cross-bridge kinetics became faster compared to high Pi and
H+ with ATP; specifically, ton recovered back to (type I) or become faster than control
(type II) and rate of myosin force production (2πb) exceeded control levels in both fiber
types. These results agree with previous non-fatigue studies in rabbit psoas fibers
showing that, compared to ATP, dATP resulted in a faster rate of tension redevelopment
(ktr), which indicates longer toff, as well as increased unloaded fiber velocity by 30%
(Regnier & Homsher, 1998), which indicates shorter ton. Fibers that contracted with
dATP versus ATP in normal conditions exhibited quicker N- (nucleotide) TPase (Regnier
et al., 1998), which represents a slower cross-bridge cycle rate due to shorter ton and/or
toff. Because rabbit psoas fibers are primarily fast-contracting, myosin-heavy chain
(MHC) II isoforms (Hamalainen & Pette, 1993), this could explain why Regnier et al.
observed quicker velocity (indicating shorter ton) with dATP versus ATP that was similar
to changes in type II fibers in the present study; specifically, type II fibers exhibited
shorter ton and type I fibers had similar ton relative to control conditions, even with high Pi
and H+. The current study also agrees with the only other study to examine high Pi and
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low pH with dATP but in isolated proteins, which showed that actin filament velocity,
and theoretically ton, returned to control levels in high Pi and H+ conditions with dATP
instead of ATP (Longyear et al., 2014). dATP most likely quickens cross-bridge kinetics
because it has a lesser affinity for myosin than ATP (Regnier et al., 2000).
Compared to ATP and ADP, myosin is thought to hydrolyze dATP faster and
therefore shorten toff, while dADP may be released faster from myosin than dATP, thus
shortening ton (Koretz & Taylor, 1975; Chock, 1979). These hypotheses were supported
by quicker fiber NTPase observed with dATP versus ATP as an energy source under the
same conditions (Regnier et al., 1998). Future work could examine the effect of dATP on
toff using the ATPase assay (ton + toff) and sinusoidal analysis (ton) in order to determine
whether changes in toff with dATP help explain the fiber-type-specific recoveries of the
number of bound heads.

5.3.2 High Pi and H+ (low pH) with dATP Partially Recovered Fiber Tension
Theoretically, because cross-bridge kinetics recovered back to control levels or
beyond in elevated Pi and low pH conditions with dATP versus ATP, the number of
strongly bound myosin heads and fiber tension (force/CSA) was also expected to recover.
However, in high Pi and H+ conditions with dATP, parameter C (which likely represents
the number of strongly bound myosin heads in this study) recovered back to control
values in type I fibers but remained low in type II fibers. Even with this fiber-typespecific recovery of the number of strongly bound heads, fiber tension only partially
recovered in high Pi and H+ conditions with dATP in both fiber types to levels higher
than high Pi and H+ with ATP but significantly lower than control. Notably, non-fatigue

	
  

72

studies in animal fibers showed no difference in maximal force between ATP and dATP
at 10°C (Regnier et al., 1998; Regnier & Homsher, 1998), which may partially explain
why dATP did not fully recover tension back to control levels in human single fibers.
Overall, the exact mechanisms for this partial recovery of tension in high Pi and
H+ conditions with dATP are unknown, but this work provides the foundation for future
studies by characterizing the molecular basis for these single fiber alterations, as
mentioned in the previous section. Our laboratory plans to test human skeletal muscle
fibers from older adults for maximal tension in a control condition with dATP compared
to control with ATP to further characterize the mechanisms of fiber improvements with
dATP in human tissue and determine if elevated Pi and H+ metabolites are inhibiting full
tension recovery.

5.3.3 dATP did not Alter Myofilament Lattice Stiffness with High Pi and H+
(low pH)
Myofilament lattice stiffness (parameter A) was the same in elevated Pi and low
pH conditions with dATP and ATP in type I and II fibers, indicating that stiffness was
unaffected by dATP. Therefore, type I fibers remained stiffer than control in solution that
contained high Pi and H+ with dATP, and stiffness of type II fibers remained unchanged
in all three experimental conditions. These results suggest that elevated Pi and/or low pH
are responsible for increased myofilament stiffness in type I fibers, whereas type II fibers
are unaffected by increased levels of these metabolites. Previous studies also found
similar fiber stiffness (determined with 0.5 kHz sinusoidal oscillations) in control
conditions with ATP and dATP, which was hypothesized to be due to similar force per
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cross-bridge in each condition (Regnier et al., 1998; Regnier & Homsher, 1998) because
active fiber stiffness is partially dependent on cross-bridge stiffness. This could indicate
that the increased stiffness observed in the present study was the result of increased force
per cross-bridge despite the proposed reduction in the number of strongly bound myosin
heads with high Pi and low pH.
Further analyses of the characteristics of parameter A may help elucidate why the
number of strongly bound heads and tension are altered with dATP while myofilament
stiffness is unaffected. Once again, future studies should examine ATPase to quantify
both ton and toff in order to clarify whether the number of strongly bound myosin heads
changes with dATP. This would help us clarify whether changes in parameter C represent
changes in the number or stiffness of myosin heads, which would also help explain
changes in myofilament stiffness.

5.4 Limitations
The present study observed a 23-28% drop in maximal fiber tension (force/CSA),
which is similar to previous single fiber studies that similarly simulated fatigue by
elevating Pi and H+ at near-physiological temperatures (Fitts, 2008; Nelson et al., 2014;
Sundberg et al., 2018; Nocella et al., 2011) but is much less than the 70-80% decline in
power observed in whole muscles of older adults (Hicks et al., 2001; Katsiaras et al.,
2005; Callahan & Kent-Braun, 2011; Christie et al., 2011; Broxterman et al., 2017;
Sundberg et al., 2018). Neural drive is thought to play a minimal role in fatigue (KentBraun, 1999; Kent-Braun et al., 2002) and therefore does not likely account for this
difference. Another possibility is that there was a diffusion limitation during the in vitro
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experiments, as early research showed that the diffusion rate of Pi varied by fiber size,
which would be important because Pi affects myosin-actin interactions and therefore fiber
force (Cooke & Pate, 1985). However, a diffusion limitation was most likely not present
because maximal tension was measured at plateau and tension always leveled off before
starting sinusoidal analysis for fiber mechanics and kinetics. If diffusion of substrates and
metabolites were limited, tension would not be expected to plateau. Notably, previous
work in single fibers shows that myosin-actin cross-bridge kinetics remain constant
across fiber size, indicating that diffusion of small molecules, such as ADP or Pi, are not
limited in the myofilament lattice (Miller et al., 2015). Finally, single fiber tension may
not have declined as much as in whole muscles due to other metabolites and substrates
that change with fatigue in vivo that can alter contractile function. Although we cannot
measure calcium concentration [Ca2+] in vivo and some evidence suggests that [Ca2+]
may not drop in vivo as much as in vitro (Roos et al., 1999), transient [Ca2+] may be
reduced with fatiguing contractions in whole muscle or electrical stimulation in single
fibers (Allen et al., 1989; Westerblad et al., 1989; Lee et al., 1991), which can reduce
sensitivity and ultimately inhibit activation and myosin-actin interactions. There has been
extensive research suggesting that reduced calcium sensitivity accounts for most of the
decline in force observed with fatigue (Allen et al., 2008; Fitts, 2008; Nelson & Fitts,
2014; Debold, 2016; Debold et al., 2016), so reduced transient [Ca2+] may help explain
the differences in force or tension reduction between single fibers and whole muscles in
human skeletal muscle.
Another possible limitation is that the type II fibers in the present were not being
oscillated fast enough to adequately observe the behavior of strongly bound cross-bridges
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in active conditions. If this were the case, the myofilament stiffness (parameter A) values
observed in type II fibers in the present study would represent the maximum measureable
values and the fact that stiffness was unchanged for all three experimental conditions
would only be a methodological artifact. However, any shifts in the elasticity of the fiber
from control to high Pi and H+ conditions were observed across all oscillation frequencies
and did not appear to converge at higher frequencies, which provides evidence that
stiffness was not at its maximum for type II fibers.
Control solutions contained 5 mM Pi in order to correspond with resting Pi levels
in human calf (Pathare et al., 2005) and quadriceps (Kemp et al., 2007) muscles. Nuclear
magnetic resonance techniques have revealed that [Pi] varies by fiber type in rodent
muscle, ranging from 0.8 mM in type IIA muscle to 6 mM in type I and IIX muscle
(Kushmerick et al., 1992). Varying [Pi] leads to altered fiber force, especially at
concentrations lower than 10 mM (Millar & Homsher, 1990). Due to the nature of our
experiments, fiber type cannot be discerned before testing fibers so this is an inherent, but
relatively minor, limitation of the study.
Finally, this study did not examine a control condition with dATP to determine
the effects of dATP on contractile function independent of elevated Pi and H+. This made
it difficult to determine the exact mechanisms of dATP. For example, without a control
with dATP condition, this study cannot determine whether the improvements observed
with dATP in high Pi and H+ conditions were because replacing ATP with dATP
improved fiber function and resulted in fibers starting at a higher baseline. In this case,
fiber function would have remained better than control despite high Pi and H+ conditions
instead of recovering the negative effects of elevated Pi and H+.
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5.5 Summary
This study provided novel mechanistic insight into skeletal muscle fatigue and its
reversal in single fibers from older men and women. Fatigue simulated with elevated Pi
(from 5 to 30 mM) and low pH (from 7 to 6.2) at 25°C reduced fiber tension (force/CSA)
compared to control conditions due to fewer strongly bound myosin heads resulting from
slower cross-bridge kinetics, including longer ton, which had not been previously
measured in single fibers with high Pi and H+ conditions. Elevated Pi and low pH with
dATP instead of ATP as an energy source recovered cross-bridge kinetics back to control
values, which resulted in full recovery of strongly bound myosin heads in type I but not
type II fibers. High Pi and H+ with dATP only partially recovered tension in both fiber
types. Interestingly, myofilament lattice stiffness increased with high Pi and H+ in type I
fibers only and was unaffected by dATP in both fiber types. These results improve our
understanding about the mechanisms of skeletal muscle fatigue in human single muscle
fibers by revealing that slower cross-bridge kinetics (longer myosin attachment times (ton)
and slower rates of myosin force production) partially explained reduced maximal
tension in response to high Pi and low pH conditions. This study also found novel
evidence that replacing ATP with dATP as an energy source for muscle fibers partially to
fully reversed the contractile deficits induced with high Pi and H+, which provides a basis
for future research about dATP as a potential countermeasure for skeletal muscle fatigue.
By understanding the mechanisms of how two putative agents of fatigue, high Pi and H+,
depressed tension in single fibers and how these decrements can be mitigated, we now
further understand the cellular and molecular causes and a potential countermeasure of
reduced force, velocity and therefore power that characterize fatigue at the whole muscle
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level. Future mechanistic work should focus on characterizing the full cross-bridge cycle,
especially toff, under similar experimental conditions to further elucidate the mechanisms
of fatigue and its reversal.
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